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INTRODUCTION 
Underlying the cytoplasmic surface of the human erythrocyte membrane is a 
dense, two-dimensional network of spectrin and other proteins that provide support 
to the lipid bilayer and afford the red cell its unique flexibility (Bennett & Gilligan, 
1993). As part of the erythrocyte skeleton spectrin plays a critical role in 
maintaining the architecture of the red cell membrane by aiding in the restriction of 
the lateral mobility of integral membrane proteins. For these reasons the erythrocyte 
skeleton is necessary for the survival of the erythrocytes as they travel through the 
high shear environment of the vascular system (Lux, 1979; Elgsaeter & Mikkelson, 
1991). Spectrin was first isolated from the low-ionic strength extracts of the 
erythrocyte membrane (Marchesi & Steers, 1968; Clarke, 1971; Fairbanks et al., 
1971). Hemoglobin-free erythrocyte membranes are nicknamed "ghosts" as a result 
of their white color after hemoglobin removal. At this point a skeleton (largely 
comprised of spectrin) remains, thus the name "spectrin" originated from the 
expression "ghosts", i.e. specter. 
The basic unit of spectrin is a heterodimer, consisting of two distinct 
spectrins, a-spectrin (280 kDa) and J3-spectrin (246 kDa), associated m an 
antiparallel manner (Speicher et al., 1982). Spectrin dimers can associate in a 
"head-to-head" manner to form tetramers (Kam et al., 1977; Ungewickell & 
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Gratzer, 1978). It has been determined that the "head-to-head" assembly consists 
of an association between the N-terminal end of the a-spectrin and the C-terminal 
end of the f3-spectrin (Morris & Ralston, 1989; DeSilva et al., 1992; Speicher et 
al., 1993). The association of the spectrin heterodimer to form tetramers is 
essential to the formation of the erythrocyte skeleton and thus to the integrity of 
the membrane. Many hereditary hemolytic anemias involve spectrin mutations 
which destabilize tetramer formation (Delaunay & Dhermy, 1993; Marchesi, 
1989). 
Several other proteins, such as dystrophin, alpha-actinin, fibrin, etc. Share 
many properties similar to those of erythrocyte spectrin and are grouped as the 
spectrin super-family (Bennett & Gilligan, 1993). Thus it is important to 
understand the structural properties of spectrin. 
Amino acid (Speicher, et al., 1983) and cDNA (Sahr et al., 1990; 
Winkelmann et al., 1990) sequence analyses of human erythrocyte spectrin reveal 
that most parts of both subunits consist of homologous sequence motifs. Each 
motif consists of about 106-amino-acids in length. There are 22 sequence motifs 
in tandem in the a-spectrin and 17 sequence motifs in the f3-spectrin. These 
sequence motifs have been suggested to fold into stable structural domains, 
consisting mostly of coiled-coils of triple helices (Parry & Cohen, 1991; Speicher 
et al., 1993). Other members of the spectrin super-family also consist of similar 
sequence motifs. 
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This dissertation consisted of three parts. The objective of the first part 
was to identify the boundaries {phasing) of the suggested 106-amino-acid 
sequence motif in spectrin. We found that the first amino acid residue of the first 
structural domain of a-spectrin was 52 (Ser) (Lusitani el al., 1994). The second 
part of this dissertation addressed the issue of finding a spectrin fragment which 
was an appropriate model for the spectrin dimer. In this second part, the amide I 
peak frequencies and helical content obtained by Fourier transform infrared along 
with resistance to proteolytic digestion were used to this end. It was found that 
while the single-domain peptides exhibited substantial helical content and were 
protease resistant structures, the multiple-domain peptides were both more 
helical and more resistant to proteolytic digestion. When all of my results on 
FflR, proteolytic digestion, CD and fluorescence were considered it was found 
that the multiple-domain peptides more faithfully represented the features 
exhibited by the spectrin dimer (Menhart et al., 1996). The third part of this 
dissertation held the same objective as the second, but focused on finding an 
appropriate model to the ionic strength mediated differences found in the spectrin 
dimer. Again it was found that the multiple-domain peptides more closely 
embodied the features found for the spectrin dimer. 
PART I 
CHAPTER I 
REVIEW 
1.1 Phasing Problem 
In the first part of this dissertation, we began with the objective of 
determining the proper phasing of the canonical 106-amino-acid sequence 
motifs. This is non-obvious since both the a- and f3-spectrin polypeptides 
contain many such motifs in tandem without any obvious delimiting structures. 
For example, when regarding the repetitive sequence of letters 
ABCDABDABCDABCD it is necessary to know what four letter segment of 
sequence forms a structural domain, i.e. is the structure ABCD, BCDA, CDAB 
or DABC. Additionally, the onset of the repeating sequence motif could not 
be assumed to correspond with the start of a protein structural domain since 
both a- and f3-spectrin contain non-integral numbers of such repeats. This 
implies the existence of fractional sequence motifs, which might occur at any 
point in the sequence. In order to attack this problem, we began with the 
hypothesis that a spectrin fragment that contains a complete 106-amino-acid 
sequence motif, in the proper phase, will also contain a stable, well-folded 
structural domain (Speicher & Marchesi, 1984). Since proteolytic sensitivity 
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has been correlated to the flexibility (Fontana et al., 1986) and accessibility 
(Novotny & Bruccoleri, 1987) of peptide structures, this well folded fragment 
will be less susceptible to proteolytic digestion than fragments that have 
incorrectly phased reading frames and thus are not well-folded. If in addition to 
the complete structural domain, the peptide contains additional amino acids 
residues, the region containing the "extra" amino acid residues is likely to be 
disordered and thus very sensitive to protease digestion. We chose elastase as 
the protease to conduct these experiments because it is relatively nonspecific, 
cleaving at the C-terminal side of the small nonpolar amino acid residues G, A, 
V, L, I and S (Ardelt, 1974). Using recombinant peptides and proteolytic 
digestion we identified the first sequence motif of a-spectrin as residues 52-156 
(Lusitani et al., 1994) (Appendix I). 
PART II 
CHAPTER II 
REVIEW 
2.1 Whole Domains 
In the second part of this dissertation, we began with the objective of 
finding a suitable peptide model for the spectrin dimer. In this work we used 
Fourier transform (FT) infrared (IR) to investigate the secondary structure and 
hydrogen-bonding strength of the correctly phased recombinant spectrin 
peptides Spa52-156 (a general abbreviation where Spa represents a-spectrin 
and 52-156 is the amino acid residue numbers in a-spectrin), Spa157-262, 
Spa263-368, Spa52-262, Spa157-368 and Spa52-368 in comparison with 
native spectrin dimer. IR spectroscopy is sensitive to the interactions of the 
protein backbone as represented by C=O stretching (1600-1700 cm·1, amide I 
region) and N-H bending (1500-1600 cm·1, amide II region). Differences in the 
strength of the hydrogen-bonding of different secondary structures as well as 
within a secondary structure are represented as changes in the frequencies of 
the previously mentioned IR absorbances (Dousseau et al., 1989). For proteins 
with high a-helical content under similar experimental conditions it has been 
shown that low amide I band frequencies correspond to a large fraction of 
ordered helix versus disordered helix and thus a long helical length. This 
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ordered helix versus disordered helix and thus a long helical length. This 
frequency shift has been correlated to the difference in hydrogen bonding of 
amide groups at the end of helical segments (disordered helix) compared to 
those in the center (ordered helix) (Van Wart & Scheraga, 1978). The use of 
both FTIR and circular dichroism (CD) methods leads to more thorough 
predictions of both 13-sheet (Sarver & Kreuger, 1991) and a-helix. We found 
that the multiple-domain peptides were more faithful in representing the 
hydrogen-bonding strength and helicity found for the spectrin dimer. We also 
used protease digestion to compare the stability of the peptides. It was found 
that the single-domain peptides (Spa52-156, Spa157-262 and Spa263-368) 
form a self-contained and protease resistant structure. However, these peptides 
were least resistant to digestion, followed by the peptides with two domains 
(Spa52-262 and Spa157-368) and finally the three domain peptide (Spa52-
368). The paper describing this work has been published (Menhart et al., 1996) 
(Appendix II). 
PART III 
CHAPTER III 
REVIEW 
3 .1 Salt Effect 
The erythrocyte is subjected to much stress as it travels the circulatory 
system and must elastically deform in order to maintain the cells integrity. The 
source of erythrocyte elasticity, though still not directly known, has been 
generally attributed to the membrane skeleton and, more specifically to spectrin. 
Spectrin is a protein with unique elasticity (Elgsaeter, 1978) and flexibility 
(Fung & Johnson, 1983). The elasticity and flexibility of spectrin may have 
physiological significance in that they may be directly related to the 
deformability and elasticity of the erythrocyte itself. It has been suggested that 
the elasticity of spectrin is entropically driven (Vertessy & Steck, 1989). 
Utilizing electron micrographs it has been found that buffer with ionic 
strengths lower than physiological amounts produce an artificially elongated 
spectrin molecule when studied as part of the membrane skeletal complex (Liu 
et al., 1987; Shen et al., 1986; Byers & Branton, 1985) and when studied 
independently as a tetramer (Shotton et al., 1979). The extracted membrane 
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skeleton, and thus spectrin by association, has been found to shrink m 
increasing ionic strengths (Svoboda et al., 1992). Partially extended skeletons 
have been studied by using a 2rnM sodium phosphate and 0.05 rnM MgCh 
buffer (McGough & Josephs, 1990). This study revealed that a- and P-
spectrin of the spectrin dimer twist around one another forming a two-start 
helix with twofold rotational symmetry in which both the pitch and diameter are 
variable and coupled (McGough & Josephs, 1990). The decreasing size in 
higher ionic strength buffers has been attributed to classical charge screening 
effects (Vertessy & Steck, 1989). 
Conformational changes in spectrin upon varying ionic strengths have 
been used as a method of modeling the changes in spectrin's conformation that 
occur in vivo and are responsible for its unique flexibility. For example, it has 
been shown that the Stokes radius of spectrin is larger in low ionic strength 
buffer than in high ionic strength buffer (LaBrake, 1993). The same trend in 
Stokes radius was also seen for spectrin peptides encompassing two or three 
structural domains (Xu, 1994). In addition, using optical rotary dispersion 
(ORD) and calorimetry techniques Ralston & Dunbar (1979) detected broader 
thermal denaturation transitions for spectrin in 5 rnM phosphate with no NaCl 
than for spectrin in 5 rnM phosphate with 100 rnM NaCl. It has similarly been 
seen by proton NMR that a wider unfolding range is found for the thermal 
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denaturation of spectrin dimer in 1.5 mM phosphate buffer with no NaCl versus 
spectrin in 1. 5 mM phosphate buffer with 150 mM NaCl (Begg et al., 1994). 
In this part of the dissertation, we have shown that peptides with more 
than one structural domain expressed in tandem more accurately represented 
the structural and thermal unfolding properties of the spectrin dimer in respect 
to ionic strength differences. In the multiple-domain peptides as well as in the 
spectrin dimer we found that the temperature values for 50 % unfolding (Tm) 
were identical within experimental error as determined by thermal denaturation 
monitored by both fluorescence and CD. We found a broader range of 
unfolding for spectrin dimer in 5 mM phosphate buffer at pH7.4 with no NaCl 
(5P7.4) than in 5 mM phosphate buffer with 150 mM NaCl (PBS7.4) and have 
shown, that for this feature also, the multiple-domain peptides more closely 
replicated the spectrin dimer. From this conclusion, the interacting regions of 
the domains, i.e. the regions where the C-terminal end of the first domain 
interacting with the N-terminal end of the next, are implicated as the source of 
these salt induced unfolding differences. In addition we have re-addressed the 
elastase digestions discussed in Part II. We have obtained the N-terminal 
sequence analysis of the most prominent bands formed from the digestion of the 
multiple-domain peptides and will discuss these results in reference to the ionic 
strength induced thermal unfolding differences. It was also necessary to re-
address the FTIR discussed in Part II due to the recently discovered sample 
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contamination problem (Mitchell, 1997) that affected the FTIR data obtained 
earlier. 
CHAPTER IV 
MATERIALS AND METHODS 
4 .1 Chemicals 
All chemicals were reagent grade and were from purchased Aldrich 
Chemical Company, Inc. (Milwaukee, WI), Fisher Scientific (Pittsburgh, PA), 
or Sigma Chemical Company (St. Louis, MO), unless stated otherwise. 
Polyvinylidene difluoride (PVDF) membranes were obtained from Applied 
Biosystems (Foster City, CA); ammonium persulfate from BioRad (Richmond, 
CA); and ultrapure acrylamide and N, N - Methylenebisacrylamide from 
Shwarz!MannBiotech (Cambridge, MA). 
4.2 Oligonucleotides and Enzymes 
All oligonucleotide primers were ordered from the Biocore Facility, 
University of Notre Dame (South Bend, ID). Restriction endonucleases were 
purchased from Gibco BRL Life Technologies (Gaithersburg, MD) or New 
England BioLabs (Beverly, MA). Elastase was ordered from Sigma (St. Louis, 
MO). 
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4.3 Preparation of Competent Cells 
A three mL overnight growth of the E. coli cell line DH5a was 
prepared in Luria broth (LB). LB was prepared by adding 1 G tryptone, 0.5 G 
yeast extract and 0.5 G NaCl per 100 mL of tap water. The overnight growth 
was used to inoculate 50 mL of SOC medium in a 500 mL flask. SOC medium 
consisted of 1 % glucose solution, 1.25 mM KCl, 5 mM NaCl, 5 mM MgCh, 
0.5 mM MgS04, 10 G tryptone and 2.5 G yeast extract per liter. The 
inoculating in SOC medium was grown for 2 hours until the optical density at 
600 nm was equal to 0.15 - 0.20, with a water blank, at which point it was 
immediately chilled to 4 °C. The cells were transferred to a sterile 50 mL tube 
and collected by centrifugation in a Sorvall RT6000B refrigerated table top 
centrifuge at 2800 x g for 5 minutes at 4 °C. The supernatant was decanted and 
the packed cells were resuspended with 16 mL of RF-1 solution and allowed to 
sit on ice for 15 minutes. RF-1 solution contained 12 G RbCl, 9. 9 G MnCh, 
2.9 G K02H2, 1.5 G CaCh and 15% glycerol per liter at pH 5.8. The cells were 
again collected by centrifugation as described above and the RF-1 solution was 
decanted. The cells were resuspended in 4 mL ofRF-2 solution and fast frozen 
with liquid N2 in 200 µL aliquots for storage at -80 °C. RF-2 solution 
contained 10 mM MOPS, 1.2 G RbCl, 11.0 G CaCh•4H20 and 15% glycerol. 
The pH of RF-2 was adjusted to 6.8 with NaOH. Both RF-1 and RF-2 were 
not autoclaved but were instead filtered through sterile filters into sterile 
containers. 
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4.4 DNA Manipulations 
4.4.1 Oligonucleotide Purification 
Further purification of the oligonucleotides was carried out usmg 
Waters Oligo-Pak Synthetic Oligonucleotide Purification Columns (Millipore 
Corporation, Milford, MA), following the instructions provided. Briefly, 5' 
DMT protected oligonucleotides were cleaved from their synthesis column 
overnight using a 30% ammonium hydroxide solution. The recovered 
oligonucleotides were loaded onto a preconditioned Oligo-Pak column, the 
failure sequences were eluted using a 3% ammonium hydroxide solution and the 
column was washed with deionized (DI) water. Then the purified 
oligonucleotides were detritylated ( dimethoxytriphenylmethyl) by washing with 
2% trifluoroacetic acid (TF A) followed immediately by rinsing with DI water to 
remove the excess TF A. The detritylated oligonucleotides were eluted from the 
column using a 20% acetonitrile solution and then lyophilized and stored at -20 
oc. 
4.4.2 Polymerase Chain Reaction (PCR) 
The design of the primers was described in a published paper (Menhart 
et al., 1996) (Appendix II). After the PCR reaction was carried out the 
products were purified using Magic PCR Preps (Promega, Madison, WI), 
following the instructions provided for purification without a vacuum manifold. 
Briefly, a sample was prepared by vortexing with Direct Purification Buffer and 
then adding Magic PCR Preps Resin and vortexing several more times over one 
minute. Next, the sample was purified by addition of the resin mixture to a 
Magic Minicolumn, washing with 80% isopropanol and drying by brief 
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centrifugation at 12,000 x g. The DNA was eluted by addition of TE buffer (10 
mM Tris-HCI, 5 mM EDTA at pH 7.5), waiting for 1 minute and brief 
centrifuging at 12,000 x g. The DNA was stored at -20 °C. 
4.4.3 DNA Digestions 
Restriction enzyme digestions of plasmid and PCR product DNA were 
carried out in the buffers provided by the manufacturer for each enzyme and 
under the recommended conditions. All reactions were made to a total volume 
of 20 µL which included 2 µL of 1 Ox reaction buffer, 2 U of each restriction 
enzyme, 1-3 µL of DNA (depending on the concentration) and 14-17 µL of DI 
water. The reactions were incubated at 3 7 °C for 3 hours, stopped and 
visualized by addition of DNA loading buffer and running on 1 % agarose gels 
as described in section 2.4.4. 
4.4.4 DNA Agarose Electrophoresis 
To prepare the digest samples for electrophoresis 5 µL of DNA loading 
buffer, 50% glycerol, 1 % sodium dodecyl sulfate (SDS) and 200 mM 
ethylenediamine tetraacetic acid (EDT A) with bromophenol blue were added to 
the DNA samples. The samples were then separated on a 1 % agarose gel. 1 G 
of agarose was dissolved, by boiling, in 10 G of 1 Ox TBE buffer (105 G Tris 
base, 55 G Boric acid and 0.75 G EDTA disodium at - pH 8.3) and 90 mL DI 
water. When the solution had cooled to 60 °C, 4 µL of ethidium bromide ( 10 
mG/mL) was added. The mixture was stirred gently and then poured into a 
horizontal gel casting tray (International Biotechnologies, New Haven, CT). 
The gel was allowed to solidify before being transferred to the electrophoresis 
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chamber (International Biotechnologies, New Haven, CT) filled with TBE 
buffer. The entire DNA sample was loaded into a well and the electrophoresis 
was run at a constant voltage of 140 V until the bands had migrated the desired 
distance as monitored with a hand held ultra violet lamp (UVP, Inc. San 
Gabriel, CA). Lamda DNA samples were cleaved with either restriction 
enzyme Hindlll, Mlul, or Pvull and were run in a separate well to serve as 
molecular weight standards. Upon completion of electrophoresis the DNA 
bands were viewed using an ultra violet light table. 
4.4.5 Digested Plasmid and Digested PCR Fragment Purification 
DNA fragments were recovered from agarose gel electrophoresis by 
excising the area of gel which contained the desired fragment. The section of 
gel was then placed in a 0.5 mL microcentrifuge tube that had been prepared by 
poking a hole in the bottom with a needle, lining the inside with glass wool and 
placing the entire 0.5 mL tube into an intact 1 mL microcentrifuge tube. The 
excised gel was then centrifuged at 15,000 x g (Marathon MicroA, Fisher 
Scientific, Pittsburgh, PA) for a short time to elute the DNA from the agarose. 
The recovered DNA was then purified following the same method described 
above in section 2.4.2 for purification of PCR fragments. 
4.4.6 DNA Ligation 
Each ligation reaction mixture contained 4 µL of 5x ligation buffer 
(provided with the enzyme), 2 units of T4 ligase, 2µL of each DNA fragment 
and 5 µL of DI water. The reactions were allowed to proceed at 15 °C 
20 
overnight and then the T4 ligase was inactivated at 70 °C before the DNA was 
transformed. 
4.4.7 DNA Transformation into Competent Cells 
A 200 µL aliquot of competent cells prepared as described above in 
section 2.4 were thawed on ice. Ligated DNA was added to the cells, so as it 
was not over 10% of the total volume, and the cell/DNA mixture was incubated 
on ice for 1.5 hours. Then the mixture was heat shocked in a 42 °C water bath 
for 1.5 minutes. Next ~ 1.5 mL of SOC medium was added and the cells were 
grown for 1. 5 hours, to allow expression of the antibiotic resistance gene, 
before being plated onto an LB plate containing the appropriate antibiotic. 
Transformants were screened for the proper DNA by identifying the presence of 
plasmid DNA, purified from the transformant as described below in section 
2.4.8, and then confirming the plasmids contents through selected restriction 
enzyme digestions. When a correct transformant was identified it was stored as 
a glycerol freeze down. An 800 µL overnight of the desired transformant was 
added to 200 µL of 100% glycerol, mixed briefly, fast frozen with liquid N2 and 
stored at -80 °C. 
4.4.8 Plasmid DNA Purification 
To purify plasmid DNA, a 3 mL overnight growth of the cells 
containing the desired plasmid was grown in LB. The next day the overnight 
growth was divided into two 1. 5 mL microcentrifuge tubes and the cells were 
collected by centrifugation at 15,000 x g. The supernatant was discarded and 
the cells were resuspended in 200 µL of GTE buffer (50% glycerol, 25 mM Tris 
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base, 10 mM EDTA at pH-7.9) with vortexing. The cells were lysed and most 
of the chromosomal DNA and RNA were removed by addition of 400 µL of 
0.2 MNaOH, 1% SDS and incubating on ice for 5 minutes. Next, proteins and 
SDS were removed by precipitation upon addition of 4 N potassium acetate at 
pH 4.6 and placement in the -20 °C freezer for 10 minutes. The precipitate was 
removed by centrifugation at 15,000 x g for 5 minutes. To precipitate the DNA 
the supernatant was transferred to a new tube containing 500 µL of 
isopropanol, briefly mixed and allowed to sit on ice for 15 minutes. Then the 
DNA was pelleted by centrifugation at 15,000 x g for 8 minutes. The 
isopropanol was discarded and the pellet was washed once with 70% ethanol. 
The ethanol was poured off and the pellet was allowed to dry under vacuum for 
- 2 hours. The pellet was resuspended in 12 µL of TE buffer with 100 µG/mL 
RNase and stored at -20 °C. 
4.5 Expression of Spectrin Fusion Proteins 
An overnight culture of cells with the desired spectrin fusion protein 
plasmid was diluted 20 fold into 4 L of fresh Terrific Broth (TB), in the 
fermenter carboy (Lab line Instruments, Rosemont, IL), with an ampicillin 
(antibiotic) concentration of lOOmG/L. The TB was prepared earlier by mixing 
12 G tryptone, 24 G yeast extract, 4 mL glycerol and 900 mL tap water, 
followed by autoclaving. Also prepared and autoclaved was 2.31 G KH2P04 
monobasic and 12.54 G K2HP04 dibasic in 100 mL DI water. After 
autoclaving the two solutions were combined to make TB. 400 µL of Antifoam 
289 (Sigma Chemical Company, St. Louis, MO) was also added to the carboy. 
The carboy was then placed into the constant temperature chamber (3 7° C) and 
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allowed to rotate at 300 rpm, with an air flow of 10 L/min, to allow cells to 
grow to mid-log phase (optical density at 600 nm equal to 0.6-1), usually about 
3 hours. At this time expression of the spectrin fusion protein was induced by 
adding isopropylthiogalactosidase to a final concentration of O. lmM. Induced 
cells were allowed to grow for about 3 more hours, until the OD600 = 1.5 -2.5, 
before being harvested by centrifugation at 7,000 x g in a Sorvall RC-SB 
refrigerated centrifuge (DuPont Company, Wilmington, DE) at 4° C. The 
supernatant was decanted and, if necessary, the packed cells were stored at -20° 
C. 
4.6 Purification of Fusion Proteins 
Packed cells from a single growth were resuspended in 1/4 w/v of 5 mM 
Na-P04, 150 mM NaCl, 1% Triton X-100 at pH 7.4. The resuspended cells 
were then lysed by mild sonication on ice and then centrifuged at 10,000 x g for 
5 minutes at 4 °C. The fusion proteins, glutathione - S - transferase (GST) -
thrombin cleavage site - spectrin peptides, were separated from other lysate 
proteins via passage over a glutathione (GSH) affinity column (GSH -
Sepharose 4B resin from Pharmacia). The column was washed with 10 
volumes of 5 mM phosphate, 150 mM sodium chloride at pH 7.4 (PBS7.4) 
followed by fusion protein elution with 50 mM Tris and 5 mM GSH at pH 8. 
4. 7 Thrombin Cleavage of Fusion Proteins 
Dithiothreitol (DTT) was added to the purified fusion protein to a 
concentration of 1 mM to facilitate removal of GSH. Without the addition of 
DTT the samples were found to be contaminated with GSH despite thorough 
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dialysis. The fusion protein was then dialized in Tris 25 mM pH 8.6 and 
cleaved with 200 U of thrombin per µmol of fusion protein. The reaction was 
carried out at 37° C, with agitation, for 1 hour. 
4.8 Purification of Cleaved Peptides 
The thrombin cleaved protein was passed over the GSH affinity column 
to separate spectrin peptide from free GST and any uncleaved fusion protein. 
The spectrin peptide was eluted with PBS7.4. When needed the peptides were 
further purified by either fast protein liquid chromatography (FPLC), with a 
Mono Q column (Pharmacia, Piscataway, NJ), using 40 mM Tris at pH 7.5 and 
a sodium chloride gradient, or size exclusion chromatoghraphy (G-75), using 
PBS7.4. Purified spectrin peptides were dialized into 5 mM phosphate buffer at 
pH 7.4 (5P7.4) and concentrated to 1-5 mG/mL before being stored at -80 °C. 
For studies in PBS7.4, 3M NaCl was diluted 20x into a sample already in 5P7.4 
to give a final NaCl concentration of 150 mM and the sample was allowed to 
equilibrate overnight at 4 °C. The concentrations of the purified spectrin 
peptides was determined by absorbance values at 280 nm, using extinction 
coefficients determined from their primary sequence by ProtParam (Parker & 
Berkowitz, 1986). 
4.9 Spectrin Peptide Characterization 
The integrity of the peptide samples was analyzed by SDS-
polyacrylamide gel electrophoresis (PAGE) as described below in section 2.12, 
by amino-acid sequencing of the N-terminal residues (Biocore Facility, 
University of Notre Dame, South Bend, IN) and by time of flight/matrix -
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assisted laser desorption ionization mass spectrometry (Wistar Mass 
Spectrometry/ Sequencing Facility, Philadelphia, PA). To determine whether 
the peptides formed aggregates in PBS7.4, the solution molecular masses of the 
peptides, at 0 .1-1 mG/mL concentrations, were determined at 4 °C with an 
absolute molecular mass determination instrument (PD2000; Precision 
Detectors, Inc., Amherst, MA). The intensity of light scattered at 15° and 90° 
from a 630-nm laser, and the refractive index were monitored as the peptide 
under investigation eluted from a G-75 column. Data were analyzed to give 
solution molecular mass distribution profiles (Freifelder, 1982). 
4 .10 Elastase Digestion 
An elastase solution (1 mG/mL elastase in 5 mM Tris-HCI buffer at pH 
5.0) was prepared. Spectrin peptide solutions (lmG/mL) were dialyzed against 
50mM Tris buffer at pH 8.75 (Ardelt, 1974). Enzyme/protein ratios (w/w) of 
1:100 (Winograd et al, 1991), 1:50, 1:25 and 1:12.5 were used. It was 
determined that at room temperature the 1: 12.5 ratio showed complete 
digestion in a 7-10 hour time frame. Digestion progression was monitored by 
taking samples at numerous time points and by visualizing digestion products 
with SDS-PAGE (section 2.12). The band intensities on the dried gels were 
digitized with a Scanmann II scanner (Logitech, Freemont, CA) at a resolution 
of 400 dpi. The relative protein content of individual bands was determined by 
integration of digitized images in each lane, using the SigmaGel program 
(Jandel Scientific Software, San Raphael, CA). Time constants for the 
disappearance of each peptide ( -c8) were determined by fitting the initial band 
intensity (Io) at t = 0 and the remaining band intensity (I) at each time point (t), 
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to a simple exponential decay curve, 1/10 = exp(thg). Molecular masses of the 
initial peptides, as well as the digestion products, were estimated by comparison 
with standards of known molecular mass. 
4.11 Protein SDS-PAGE 
The SDS-PAGE was conducted as described by Laemmli (Laemmli, 
1970) with modifications . The separating gel contained 16% (w/v) 
acrylamide, 0.43% (w/v) N, N' - methylene bisacrylamide, 375 mM Tris (pH 
8.8), 0.1 % (w/v) SDS, 0.03% (w/v) ammonium persulfate, 0.07% (v/v) 
TEMED. The stacking gel was made of3.8% (w/v) acrylamide, 0.1% (w/v) N, 
N' - methylene bisacrylamide, 125 mM Tris (pH 6.6), 0.05% (w/v) ammonium 
persulfate, 0.07% (v/v) TEMED. Electrophoresis samples were prepared by 
adding the appropriate amount of 6x SDS loading buffer to a protein sample. 
The loading buffer contained 300 mM Tris-HCI at pH 6.8, 12% SDS, 0.6% 
bromophenol blue, and 60% glycerol. The electrophoresis was run in a Mini-
PROTEAN II electrophoresis cell at a constant current of 30 mAmp. The gel 
was stained in a solution containing 50% methanol, 10% acetic acid and .005% 
coomassie brilliant blue, then destained in a solution containing 7% acetic acid. 
4.12 Electroblotting for Amino Acid Sequencing 
Prior to amino-acid sequencing the spectrin peptide was digested with 
elastase and the product was separated with SDS-P AGE. Immediately 
following electrophoresis the samples were electroblotted onto a polyvinylidene 
diflouride (PVDF) membrane, as directed by the manufacturer. A ProBlott 
membrane (Applied Biosystems) was wet with methanol for a few seconds and 
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then soaked in electroblotting buffer ( 1 OmM CAPS at pH 11. 0 and 10% 
methanol) for 5 minutes along with the electrophoresis slab gel. The 
transblotting sandwich was assembled and the electroblot was run, at 4 °C, in 
the Mini Trans-Blot Cell (BioRad Laboratories, Hercules, CA) for about 90 
minutes at 300mA and lOOV then removed and rinsed thoroughly with 
deionized water. The membrane was then stained (0.1 % (w/v) coomassie blue; 
40% (v/v) methanol; 1 % (v/v) acetic acid) for 5 minutes followed by destaining 
with several changes of 10% (v/v) methanol. The membrane was allowed to air 
dry and then sent to the Amino Acid Sequencing Facility at the University of 
Illinois Champaign for amino-acid sequencing of the first 9 amino acids in the 
desired peptide fragment. 
4.13 Spectrin Dimer Preparation 
As described previously (LaBrake, 1993), human red blood cells 
(RB Cs) were obtained from the local blood bank and used within one week of 
withdrawal. All steps were carried out at 4 °C unless specified otherwise. 
RBCs were washed 3 times with 5 mM sodium phosphate buffer with 150 mM 
NaCl at pH 8.0 (PBS8). White membrane ghosts were prepared by lysing the 
washed RBCs with 20 volumes of 5 mM phosphate at pH 8.0 (5P8) and then 
washing the membrane 3 times with the same buffer, according to the method 
of Dodge et al. (1963). The spectrin dimer preparations were done according 
to published methods (Ungewickell & Gratzer, 1978; Budzynski, et al., 1992). 
The membrane ghosts were washed once with 0. 3 mM phosphate buffer at pH 
7.6 (0.3P7.6), followed by incubation with 2-3 volumes of 0.3P7.6 for 30 
minutes at 37 °C. After incubation at 37 °C , the membranous solution was 
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centrifuged at 400,000 x g in an ultracentrifuge for 20 minutes. The 
supernatant containing the spectrin-actin complex was pooled and concentrated 
with an ultrafiltration cell (Amicon, Danvers, MA) to a concentration of about 
1.5 mG/mL. The spectrin concentrations for the experiments were determined 
using an extinction coefficient at 280 nm of 1.0 (Clarke, 1971). The spectrin-
actin solution was loaded onto a gel filtration column (Sepharose 4B-CL, 
Pharmacia, Piscataway, NJ) equilibrated with 25 mM Tris, 5 mM EDTA and 
100 mM NaCl at pH 7.6 and eluted at a flow rate of 22 mL/hr for about 16 
hours. The spectrin dimer fractions were pooled and stored at -80 °C. 
4.14 Fourier Transform Infrared (FTIR) Spectroscopy 
FTIR spectra were collected as described previously (LaBrake et al., 
1993). Samples at 10-30 mG/mL in 5P7.4 were used. Spectra were collected 
using a Bio-Rad FTS-40 FTIR spectrophotometer with a triglycine sulphate 
detector at the University of Illinois at Chicago. Typically, 1024 interferograms 
were recorded, co-added, triangularly apodized and Fourier transformed to give 
a single beam spectrum with a resolution of 4 cm·1. All measurements were in 
H20 buffer, a semi-permanent cell equipped with CaF2 windows and a 6 µm 
spacer from Graseby Specac Inc (Fairfield, CT) was used. A water vapor single 
beam spectrum was collected in the presence of an empty cell and reduced N2 
purge. For each spectrin peptide a single beam spectrum was collected on the 
spectrin peptide, on the buffer/background (filtrate from sample concentration) 
and on a clean empty cell (air). 
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4 .15 FTIR Data Analysis 
All data manipulations were performed using either Spectra-Cale or 
GRAMS software (Galactic Ind., Salem, NH) and were carried out as 
previously described (LaBrake et al, 1993). 
4.15.1 Absorbance Spectra 
The IR absorbance spectra of the spectrin samples were calculated from 
the single beam intensity spectra. The log of the ratio of the single beam 
spectrum of the sample of spectrin peptide to that of air was taken. In the same 
way, the absorbance of the background referenced to air was determined. 
4 .15 .2 Background Subtraction 
To obtain the absorbance spectrum of a spectrin peptide corrected for 
the contribution of the background, the background absorbance spectrum was 
subtracted manually using GRAMS software. The subtraction was carried out 
by varying the scaling factor of the background spectrum until the difference 
spectrum displayed a flat baseline in the region of 1700-2000 cm·1. Peak 
positions were obtained from the corrected absorbance spectrum. 
4.15.3 Partial Least Square Analysis 
The absorbance spectra of the spectrin peptides were analyzed using the 
Dousseau & Pezolet (1990) method as previously described (LaBrake et al., 
1993). The spectra were prepared for analysis with Spectra-Cale software by 
setting spectral limits from 1480 to 1720 cm·1, adjusting a flat baseline with a 
two-point baseline correction, setting the baseline to zero and normalizing the 
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total intensity to unity. The analysis was carried out using the PLS-QUANT 
option in the Spectra-Cale software. A training set of 14 spectra with known 
secondary structure (Dousseau & Pezolet, 1990) were used to calculate the 
calibration spectrum with a dimension of 25 and four secondary structural 
element components: ordered a.-helix, disordered a.-helix, J3-sheet and other 
(includes turns and random coil). Thus, using the PLS-QUANT option of 
Spectra-Cale, with the calibration spectrum, the relative content of the 
secondary structural elements of our peptides was predicted from their FTIR 
absorbance spectra. 
4.15.4 Amide I Peak Position Identification 
To obtain the amide I peak position the absorbance spectra were 
smoothed using a FTT (Fast Fourier Transform) filter (cutoff of 6 cm-1) to 
further remove sharp peaks associated with H20 vapor. Hopefully, smoothing 
did not lower resolution as the halfwidths of the solution phase amide I peaks 
are broad, ranging from -30-35 cm·1, while the halfwidths of the vaporphase 
H20 peaks are comparatively narrow, -3 cm·1. The peak position was then 
chosen as the peak maximum. 
4.16 Circular Dichroism (CD) 
Thermally induced unfolding of the spectrin peptides and spectrin dimer 
was monitored by CD at 222 nm, every 0.5 °C, using a Jasco 710 CD 
spectrophotometer and a thermostated (water jacketed) cell with a 0.1 cm path 
length at the University of Illinois at Chicago. The temperature was increased 
continuously at a rate of 1° /min. All samples had an absorbance at 280 nm of -
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0.3 and were in the presence of either PBS7.4 or 5P7.4 buffer. A CD222 reading 
was obtained every 0.5 °C. The molar ellipticity at 222 nm, 8222 (degree cm2 
dmor1), was calculated. To determine a-helical contents we used the method 
described for dystrophin, which has a similar structure to spectrin, by using 8 222 
= -36,000 degrees cm2 dmor1 to represent peptides with 100% a-helical 
structure (Kahana et al, 1992). 
4 .17 Fluorescence 
Thermally induced unfolding of the spectrin peptides and spectrin dimer 
was monitored by flourescence spectroscopy, using Hitachi F-2000 
fluorescence spectrophotometer equipped with a thermostated cell holder. A 1 
cm path length cuvette was used, with sample stirring, while the temperature 
was raised 1°/min and was monitored within the sample itself All samples had 
an A2so = 0.02 and were in the presence of either PBS7.4 or 5P7.4 buffer. An 
excitation wavelength of 278 nm was used and the emission spectra were 
collected between 315 - 385 nm every 2 °C, starting at 7 °C. The values of the 
average emission wavelength, with A.mean defined as A.mean = l,h I l, IAX1 
(Royer et al., 1993; Royer, 1995), were calculated from values of intensity (h) 
for each spectrum and used to monitor unfolding. This parameter is a more 
suitable measure of unfolding than either simple intensity measurements at a 
particular wavelength (Eftink, 1994), or a ratio of intensities at two 
wavelengths (Steer & Merrill, 1995). Since A.mean incorporates the information 
in the whole emission spectra, it is less noisy, and more sensitive to changes in 
any region of the spectra than those obtained with other generally used 
methods. 
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4.18 Data Analysis of Thermally Induced Unfolding 
We determined the temperature for 50 % unfolding {Tm) of the spectrin 
peptides and the spectrin dimer and the entropy at this temperature, .1Sm, by 
fitting the denaturation profile (fraction of unfolding versus temperature), 
obtained either by fluorescence or CD methods, to a two state (native -... 
unfolded) denaturation model. This was done by using a nonlinear least squares 
minimization routine in conjunction with a series of equations that described the 
system detailed below. 
4.18.1 Baseline Correction 
Well away from the transition, both states (native, N, and unfolded, U) 
were observed to exhibit spectral properties (<I>) that were linear functions of 
temperature. This baseline has commonly been approximated by a linear 
relationship (Eftink, 1994; Shortle et al., 1988; Stafford, 1985): 
<l>N(T) = <l>N,O + bN * T 
<l>u(T) = <l>u,o + bu * T 
(1) 
(2) 
where <l>N,o and <l>u,o are the spectral properties at a reference temperature (here 
chosen to be 0 °C for convenience) of state N and state U, respectively, bN and 
bu are the slope factors obtained experimentally and T was the temperature 
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(°C). The observed spectral properties, cj>(T), at any particular temperature 
were then assumed to be a linear sum of the fractions of each component: 
cj>(T)= (1-fu)* cj>N(T)+ (fu)*cJ>u(T) (3) 
where fu was the fraction of unfolded state at the temperature T. 
4.18.2 Free Energy ofUnfolding 
The fraction of unfolded state was derived from the equilibrium constant 
expression : 
K = fu/(1-fu) (4) 
where K was the unfolding reaction equilibrium constant in the two state 
unfolding model. Since K= exp(-AG/RT) where AG was the free energy 
change for the unfolding reaction, fu was related to AG by the following 
equation: 
fu/(1-fu) = exp(-AG/RT)= exp(AH-TAS)/RT (5) 
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where MI and AS were the enthalpy and entropy change for the unfolding 
reaction. 
We have used two methods to analyze our data that differ according to 
their AG dependence on temperature. In the first method we used a linear free 
energy dependence of AG on T, i.e., the heat capacity change for the unfolding 
reaction (Cp) was equal to zero (Eftink, 1994; Shortle et al., 1988; Hancock & 
Hsu, 1997). With this method, at the temperature where 50% of the peptide 
was unfolded T=Tm, K=l and AG=O, then AH=TmAS. As Cp was assumed to 
be zero then MI and AS were temperature independent and thus AS=ASm and 
MI=TmASm in equation (5): 
fu/(1-fu) = exp(-ASm(T - Tm))/R(T+273) (6) 
This assumption was only an approximation, since Cp has been shown to 
be non-zero for most proteins (Sturtevant, 1977; Schellman, 1987; Becktel & 
Schellman, 1987; Shortle et al., 1988). However, this approximation is still 
being used (Eftink, 1994; Hancock & Hsu, 1997) since the relative magnitude 
of Cp is often not large compared to MI, AS and T. In more rigorous terms, 
the curvature o2 AG/oT2 = -Cp/T is small compared to the slope oAG/oT=ASm. 
In the second method used to analyze the unfolding profile, a more rigorous 
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equation that allows for non-zero Cp values (Shortle et al., 1988; Becktel & 
Schellman, 1987) was used: 
fu/(1-fu) = exp ((fm(AS - Cp) - (AS+ Cp)T - Cpln(T/Tm)Y(R(T+273))) (7) 
CHAPTER V 
RESULTS 
5.1 Characterization of Properly Phased a-Spectrin Peptides 
5 .1.1 Molecular Masses 
All spectrin peptides were purified to >90% purity as seen by SDS-
P AGE (for example, Appendix I - Fig. 2A and B, Fig. 3A; Appendix II - Fig. 
2A, B and C; Fig. 1). Occasionally, trace amounts of GST at ~27 k:Da were 
also detected (Appendix II - Fig. 2B and C), yet most preparations provided 
samples with at least 95% purity. 
The theoretical molecular masses calculated from the ammo acid 
sequence, experimental molecular masses as estimated from the electrophoretic 
mobility and from the time of flight/matrix-assisted laser desorption ionization 
mass spectral analysis peptide masses for Spa52-156, Spa157-262, Spa263-
368, Spa52-262, Spa157-368, and Spa52-368 are summarized in Table I. It 
was found that the values obtained from mass spectrometry were all within 
0.1 % of the theoretical molecular masses. Solution molecular masses under 
non-denaturing conditions were also obtained by 15° and 90° light scattering 
intensity data in both 5P7.4 and PBS7.4. Most peptides, at ~ lmG/mL, 
exhibited molecular masses within 10% of theoretical (Table I), suggesting that 
they were all monomeric in solution. It was shown that this light scattering 
technique was able to detect oligomers of the peptide Spal-446 at this 
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SDS-PAGE of the elastase digestion products of Spa.157-
368. The first lane contained molecular mass standards. 
Subsequent lanes (lanes 2-14) contained an aliquot of each 
digestion reaction ended at various times, except for 0 h which 
contained no elastase: 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 
and 6 h. Intensities of the band for Spa.157-368 (27.2 kDa) 
decreased as a function of elastase digestion time. Spa.157-368 
eventually yielded fragments at 16.0 and 14.3 kDa. 
Table 1 - Peptide Molecular Masses (kDa) 
Protein theoreticaI3 mass electrophoresisc light scatteringa 
sEectrometryb 
5P7.4e PBS7.4r 
Spa52-156 12.65 12.64 12.2 11.9 11.4 
Spa.157-262 12.24 12.39 12.3 9.8 12.4 
Spa263-368 12.06 12.21 12.1 12.7 12.3 
Spa.52-262 24.87 24.86 28.8 21.5 23.5 
Spal57-368 24.28 24.43 27.2 26.3 25.9 
Spa52-368 36.92 36.92 37.2 35.1 34.4 
a Values calculated from the amino acid sequence. 
b Obtained from time of flight/matrix-assisted laser desorption ionization mass spectrometry. Values from one run, all fall within 0.1% of 
theoretical values. 
0 Estimated from 16 % SDS-PAGE data with IO% uncertainties. 
d Average values obtained from PDI data, see section 2.9, generally from two runs, all fall with 10% uncertainties. 
•Samples in buffer of 5 mM phosphate at pH 7.4. 
c Samples in buffer of 5 mM phosphate and 150 mM NaCl at pH7.4. 
w 
-.l 
38 
concentration. Considerable amounts of both dimer and trimer were detected 
(Appendix II - Fig. 2). 
5.1.2 N-terminal Amino Acid Sequencing 
The first 8-9 amino acid residues obtained from N-terminal amino acid 
sequencing agreed with the assumed sequences of the peptides. 
5.1.3 Fourier Transform Infrared (FTIR) Spectra 
The single-domain peptides (Spa52-156, Spa157-262 and Spa263-
3 68) all have the location of their amide I peak frequency centered at - 1652 
cm-
1
. The multiple-domain peptides, Spa52-262, Spa157-368 and Spa52-368, 
are more similar to the spectrin dimer with peaks centered at -1651 cm -1. The 
spectrin dimer had its peak centered at -1650 cm -l (Table II, Fig. 2). Results 
on the relative content of secondary structural elements showed that Spa52-
156, Spa157-262 and Spa263-368 exhibited 35, 69 and 57 % helical content in 
5P7.4, respectively. Spa52-262, Spa157-368 and Spa52-368 exhibited 69, 65 
and 82 % helical content in 5P7.4, respectively. In the same conditions the 
spectrin dimer exhibited 67 % helical content (Table II). 
5 .1. 4 Circular Dichroism (CD) - Helical Content 
At 20 °C no significant difference was found for a peptides helicity in 
PBS7.4 versus 5P7.4 (Table III). The helical contents for Spa52-156, Spa157-
Table 2 - Structural Properties Derived from FTIRa 
Proteinc Amide I (cm-1)d 
Spa.52-156 (n = 2) 1652.0 ± 0.7 
Spa.157-262 (n = 2) 1652.0 ± 0.4 
Spa.263-368 (n = 3) 1652.3 ± 0.2 
Spa.52-262 (n = 2) 1650.8 ± 0.3 
Spa.157-368 (n = 2) 1650.7 ± 0.2 
Spa.52-368 (n = 2) 1650.6 ± 0.1 
Spectrin dimer (n = 1) 1649.9 
a All runs were at room temperature, - 20 °C, and were in 5P7.4. 
b PLS analysis of FTIR spectra 
c n always represents the number of runs. 
d All errors were the standard deviation of multiple runs (crn. 1). 
% Helix 
35 ± 10 
69± 3 
57± 5 
69±0 
65 ±4 
82± 1 
67 
Secondary Structural Elementsb 
% 13 - sheet % Other 
21 ±7 36±6 
9±5 21 ±0 
14±4 29±2 
12± 2 20±2 
13 ± 2 23 ± 3 
6±1 13 ± 1 
19 32 
w 
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40 
FTm spectra of Spa52-156 (dashed olive line), Spa157-262 
(dashed blue line), Spa263-368 (dashed green line), Spa52-
262 (dotted magenta line), Spa157-368 (dotted purple line) 
and Spa52-368 (solid yellow line) normalized to peak area. 
The average amide I peak center for the single-domain peptides 
was 1652 cm-1 and was 1651 cm-1 for the multiple-domain 
peptides. The amide I peak height reflects the helicity. The 
greatest average helicity was found for the three-domain peptide 
Spa52-368 (82 %). The two-domain peptides, Spa52-262 and 
Spa157-368, followed with helicities of 69 % and 65 %, 
respectively. Finally the single-domain peptides, Spa52-156, 
Spa157-262 and Spa263-368, showed the least helicity m 
general with values of 3 5 %, 69 % and 57 %, respectively. 
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Table 3 - Structural Properties Derived from cn•,b,c 
Protein 
Spa.52-156 
Spa.157-262 
Spa.263-368 
Spa.52-262 
Spa.157-368 
Spa.52-368 
Spectrin dimer 
5P7.4 
48 ± 1(n=3) 
72 ± 2 (n = 3) 
58 ± 2 (n = 3) 
77 ± 3 (n = 2) 
70 ± 2 (n = 3) 
81±2 (n = 5) 
53 ± 6 (n = 3) 
• All runs were at room temperature, - 20 °C. 
% helix 
PBS7.4 
52 ± 3 (n = 3) 
75 ± 3 (n = 3) 
61±1 (n=3) 
75 ± 2 (n = 2) 
72 ± 2 (n = 3) 
79 ± 2 (n = 4) 
60 ± 10 (n = 3) 
b n always represents the number of runs. Generally two separate protein preparations of each peptide were used. No 
variation outside of the error found for separate runs on one preparation was found for the error of the two preparations. 
0 All errors were the standard deviation of multiple runs (crn-i) 
~ 
N 
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262 and Spa263-368 were 48, 72 and 58 % in 5P7.4 and 52, 75 and 61 % in 
PBS7.4, respectively. The helical contents for Spa52-262, Spa157-368 and 
Spa52-368 were 77, 70 and 81 % in 5P7.4 and 75, 72 and 79 % in PBS7.4, 
respectively. The helical contents for the spectrin dimer were 53 % in 5P7.4 
and 60 % in PBS7.4. 
5 .2 Elastase Digestions 
The results of elastase digested Spa52-262 and Spa52-368 were 
published (Appendix II). Spa52-262 was digested to 16.5 kDa, 14.5 kDa and 
12.9 kDa bands (fragments). The first six residues of the most prominent band, 
14.5 kDa, were GSSYHL, as shown by N-terminal amino acid sequencing. The 
residues GS were from the thrombin digestion site and the rest corresponded to 
amino acid residues 52-55 of a-spectrin. Spa52-368 was first digested to 30.5 
and 28.3 kDa bands and next to 16.0 and 14.2 kDa bands. The first six 
residues of the most prominent band, 14.2 kDa, were also GSSYHL. 
Spa157-368 appeared as a single band at 27.2 kDa in the presence of a 
mild contamination at -20 kDa (Fig. 1, lane 2). Spa157-368 was digested to 
two bands of 16.0 and 14.3 kDa (Fig. 1, lanes 3-10). The first six residues of 
the most prominent band, 14.3 kDa, were GSALKF, with GS corresponding to 
the thrombin digestion site and ALKF corresponding to amino acid residues 
15 7-160 of a-spectrin. 
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5.3 Thermal Unfolding 
As described in Chapter IV (Materials and Methods) two methods were 
used to analyze our data. The data were fitted to equations 6 and 7 by the non-
linear curve fitting program provided by Origin (Microcal Software, Inc., 
Northampton, MA) to give the parameters: AS, Tm and Cp. Standard errors of 
these parameters were also obtained from the program. Parameters obtained 
with the assumption that Cp=O (Eqn. 6) of a representative CD spectrum of 
Spa.52-156 were as follows, ASm = 526.9 ± 1.2 J/mol•deg and Tm= 44.0 ± 0.1 
°C. The parameters obtained without assuming Cp = 0 (Eqn. 7) were AS = 
526.9 ± 392.9 J/mol•deg, Tm= 44.0 ± 558. 7 °C and Cp = -0.02 ± 464.24. The 
curve fitting with equation 7 gave essentially the same AS and Tm values as the 
curve fitting with equation 6. The value for Cp obtained from equation 7 was -
0.02, which was much less than the value for AS (527 J/mol•deg). This 
justified the linear AG approximation (Eqn. 6) since the curvature B2 AG/BT2 = -
Cp/T (Becktel & Schellman, 1987) was thus small compared to the slope 
BAG/BT ~ AS. Since AG in equation 7 was relatively insensitive to Cp over 
small T ranges when Cp <<AS, the fitting of experimental data to this equation 
resulted in large indeterminacies for all three thermodynamic parameters. In 
particular, the calculated standard error of the parameter Cp was quite large (-
0. 02 ± 464.24). This indeterminacy also resulted in relatively large errors for Tm 
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and AS, but yielded Tm and AS values substantially identical to those determined 
by the use of equation 6. As well, the overall X2 of the fit did not improve, with 
values of 0.028 and 0.029 for equations 6 and 7, respectively. We thus 
concentrated on the parameters obtained from equation 6 (with the assumption 
Cp=O). 
The values of Tm (°C) and ASm (J/mol•deg) are summarized in Table IV 
and Table V, respectively. It was found by both CD and fluorescence that 
spectrin dimer exhibited no difference in Tm in both high salt (HS) and low salt 
(LS) buffer, with a value of ~47 °C for the Tm (Table IV). This feature was also 
found for all of the multiple-domain peptides (Spa52-262, Spa157-368 and 
Spa52-368). In the single-domain peptides (Spa52-156, Spa157-262 and 
Spa263-368) the Tm was 48, 58 and 59 °C in LS buffer and 51, 54 and 63 °C in 
HS buffer, respectively, for fluorescence and 45, 55 and 52 °C in LS buffer and 
44, 53 and 57 °C in HS buffer, respectively, for CD. 
On average the HS to LS ratio of ASm increases with an increasing 
number of domains, gradually approaching the value for the spectrin dimer (Fig. 
3). This ratio represents the difference in the cooperativity of the transitions 
between the HS and LS conditions. To express the result that suggests 
multiple-domains have an increased HS/LS ratio for ASm we compared the 
actual ratios for the multiple-domain peptides with the average ratio 
Table 4 - Midpoint Temperature (Tm, °Ct 
Protein Fluorescence ,c Circular Dichroism 
5P7.4 PBS7.4 5P7.4 PBS7.4 
Spa52-156 48 ±4 (n = 4) 51 ±2 (n = 4) 45 ±3 (n = 2) 44 (n =l) 
Spal57-262 58 ±0 (n = 2) 54 ±2 (n = 3) 55 ±2 (n = 2) 53 ±0 (n = 2) 
Spa262-368 59±1 (n=3) 63 ±1(n=2) 52 ±2 (n = 3) 57 ±2 (n = 2) 
Spa52-262 51 ±2 (n = 8) 52 ±1 (n = 6) 50 ±1(n=3) 50±1 (n=3) 
Spal57-368 61 ±2 (n = 4) 59 ±2 (n = 3) 59 ±1 (n = 3) 57±1 (n=3) 
Spa52-368 52 ±3 (n = 6) 53 ±2 (n = 6) 54 ±1(n=3) 54 ±0 (n = 3) 
spectrin dimer 46 ±0 (n = 4) 47 ±0 (n = 4) 48 ±0 (n = 2) 47(n=1) 
a Temperature with 50 % unfolded; Tm obtained from curve fitting of equation 6. 
b n represents the number of experimental runs of a single protein preparation. We had found that different protein preparations gave little 
variation in experimental observations. 
c All errors were the standard deviation of multiple runs ( crn _ 1 ). 
.i::. 
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Table 5 - L\Sm (J/molcdeg)8 
Protein Fluorescenceb,c Circular Dichroism 
PBS7.4 (HS) 5P7.4 (LS) Ratio PBS7.4 (HS) 5P7.4 (LS) Ratio 
HS/LS HS/LS 
Spa.52-156 424 ± 83 (n = 4) 358 ± 100 (n = 4) 1.19 524 (n = 1) 507 ± 91 (n = 2) 1.03 
Spa.157-262 806 ± 33 (n = 3) 890 ± 25 (n = 2) 0.91 798 ± 83 (n = 2) 981 ± 17 (n = 2) 0.81 
Spa.263-368 1214±33 (n=2) 1264 ± 158 (n = 3) 0.96 607 ± 75 (n = 2) 657 ± 141(n = 3) 0.92 
Spa.52-262 765 ± 42 (n = 6) 615 ± 33 (n = 8) 1.24 840 ± 33 (n = 3) 615 ±25 (n=3) 1.36 
Spa.157-368 1097 ± 67 (n = 3) 1064 ± 25 (n = 4) 1.03 1048 ± 67 (n = 3) 1039 ± 67 (n = 3) 1.01 
Spa.52-368 1081±75 (n = 6) 757 ± 100 (n = 6) 1.43 981 ± 67 (n = 3) 765 ± 42 (n = 3) 1.28 
Spectrin 3658 ± 524 (n = 4) 1430 ± 125 (n = 4) 2.56 948 (n = 1) 624 ± 17 (n = 2) 1.52 
dimer 
a Entropy at 50 % unfolded ; ASm obtained from curve fitting of equation 6. 
b n represents the number of experimental runs of a single protein preparation. We had found that different protein preparations gave little 
variation in experimental observations. 
c All errors were the standard deviation of multiple runs (crn-1). """ -.l 
Figure 3 
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Average ASHslASLS ratios of the spectrin peptides and of the 
spectrin dimer for fluorescence and CD. The average ratios 
for the single, Spa.52-156, Spa.157-262 and Spa.263-368, and 
two-domain peptides, Spa.52-262 and Spa.157-368, are shown 
along with the ratios of the three-domain peptide, Spa.52-368, 
and the spectrin dimer. On average the single-domain peptides 
showed no salt effect (fluorescence) or the opposite effect (CD) 
of the spectrin dimer. For both techniques the effect was seen to 
increase, towards the end of the effect seen for the spectrin 
dimer, as the number of domains increased. 
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of their parts. For example, the ratio of Spa52-162 was 1.24 for the 
fluorescence data and the average ratios for Spa52-156 and Spa157-262 was 
1.05. The ratio of these two values (RR) was 1.2. Similarly the RR value for 
CD data was 1.5. The RR of ~S for fluorescence and CD, respectively, for 
Spa157-368/Spa157-262, Spa263-368 was 1.1 and 1.2; and for Spa52-
368/Spa52-156, Spa157-262, Spa263-368 was 1.4 and 1.4. The ratios of 
~Sm in HS buffer to ~Sm in LS buffer show the effects of the addition of 150 
mM NaCl to the buffer (Table V). On average no salt effect was seen for the 
single-domain peptides (Fig. 3). The ratio was seen to increase for both two 
repeat (Spa52-262 and Spa157-368) peptides in comparison to their 
individual parts (Spa52-156, Spa157-262 and Spa263-368). The same was 
seen for the ratio of the three domain peptide (Spa52-368) in respect to its 
individual parts (Spa52-156, Spa157-262 and Spa263-368 or Spa52-262 
and Spa157-368). The salt effect ratio found for a123 begins to approach that 
of spectrin dimer (Fig. 3). 
CHAPTER VI 
DISCUSSION 
6.1 Peptide Stability from FTIR and CD Studies 
The shifts in amide I peak positions from 1651 cm-1 to 1652 cm-1 seen 
with the smaller peptides (Spa52-156, Spa157-262 and Spa263-368) are 
consistent with weaker hydrogen bonding and a larger fraction of disordered 
helix, as discussed previously in Part II (Menhart et al., 1996). In another FTIR 
study of the spectrin dimer, it was found that the peak center frequencies up-
shifted 3 cm-1 when the spectrin dimer was treated with the denaturing 
conditions of SDS and by 1 cm-1 when treated with NaOH (LaBrake et al., 
1993). 
At the high concentrations needed for FTIR, generally >I 0 mG/mL, the 
peptides studied were found to precipitate in PBS7.4. The single-domain 
peptides in particular were found to be precipitated at high concentrations (>5 
mG/mL) when in PBS7.4. This problem was not present at the concentrations 
used for the collection of CD spectra (<0.5 mG/mL). As a result the helicity of 
the peptides in PBS7.4 versus 5P7.4 was obtained only by CD methods. It was 
found that at room temperature there was no difference in helicity for either 
spectrin dimer or the spectrin peptides in the different ionic strength buffers. 
This finding was supported by another study in which the helicity of the spectrin 
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dimer in PBS7.4 versus 5P7.4 was not seen to vary as monitored by FTIR 
(LaBrake et al., 1993). 
In general the helicity of the peptides is seen to increase with the total 
number of structural domains it contains as monitored by both FTIR and CD 
(Table II, Table III). The one anomaly in this trend was found in the seemingly 
high percentage of helicity for the single-domain peptide, Spa.157-262. This 
could possibly be explained by the suggested presence of a disulfide between 
Cys(167) and Cys(224) (Mitchell, 1997). It has been shown that generally 
disulfide bonds structurally stabilize a protein (Cantor & Schimmel, 1980). 
Both the helical content (Table II) and the amide I center peak 
frequency (Fig. 2) of the peptides showed that multiple-domain peptides were 
better folded, with both greater helical contents and stronger average hydrogen-
bond strength than found for their individual parts. 
6.2 Peptide Stability from Elastase Digestion Studies 
A triple-helical bundle model has been suggested for the 106-amino 
acid sequence motif In this model the three helices are aligned side by side, 
with the first and third parallel and the intervening second helix antiparallel 
(Speicher & Marchesi, 1984; Parry et al., 1992; Speicher et al., 1993). X-ray 
diffraction studies of one such sequence motif unit from a non-erythroid 
spectrin support this model (Yan et al., 1993). In these x-ray studies, the 
peptide used was found to form a homodimer containing two triple-helical 
structures, in which two of the three helices are contributed by one monomer 
and the remaining helix by the other monomer. It is thought that this peculiar 
arrangement may be an artifact of crystallization, and the true structure of a 
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single unit may be similar to the earlier suggested triple-helical bundle with a 
zigzag arrangement of the helices (Yan et al., 1993). This arrangement aligns 
the N- and C-terminal residues at opposite ends of this triple-helical bundle, and 
thus sequential motifs are thought to be linked in tandem in intact spectrin, 
producing a very long rod-shaped molecule, approximately 100 nm in length, as 
seen by electron microscopy (Shotton et al., 1979). Recently, an NMR solution 
structure of a sequence motif unit from chicken brain a-spectrin has been 
solved (Pascual et al., 1997) and it too supports the suggested triple-helical 
bundle model (Fig. 4). 
We have used the backbone coordinates of the x-ray structure (Yan et 
al., 1993) and fitted them to our peptides. Side chains were added to the 
backbone a carbons and simple energy minimization was applied to provide a 
working model for our peptides (Fig. 5). 
Elastase digestion data suggested that the multiple-domain peptides 
(Spa52-368, Spa52-262 and Spal57-368) were digested to bands of 12-15 
kDa, corresponding to 100-130 amino acid residues. Thus the digestion 
products were likely to be fragments folded into a structural domain which 
consisted of about 106-amino-acid residues. 
Throughout the incubation of Spa52-262 with elastase, digestion 
products appeared at 16.5, 14.5 and 12.9 kDa. The prominent band was at 
14.5 kDa. When the N-terminal sequence data, the fragment size (-123 amino 
acid residues for 14.5 kDa molecular mass) and the elastase digestion sites at 
the C-terminal region were considered it was found that the potential peptides 
for this fragment corresponded to a fragment containing residues 52 to 171, 
174 or 179. Assuming that the 16.5 kDa (-140 amino acid residues) band had 
AB loop Helix A 
~ 
Helix C 
Figure 4 NMR solution structure of chicken brain a-spectrin 
(Pascual et al., 1997). The structure is of a single 
domain of chicken brain a-spectrin (16th domain). 
The different helices are labeled as Helix A (yellow), 
Helix B (red) and Helix C (blue). Helix A is the N-
terminal helix. The loop and tum linking the helices 
are grey. 
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Model of Spa.52-262. The model was created by fitting our 
sequence to the backbone coordinates of the x-ray structure. 
Energy minimization was applied to provide a working model 
for our peptide. The triple helical bundles have been designated 
as helices A, B and C, starting with the most N-terminus helix. 
The loops are designated by the regions they link, i.e., the loop 
connecting Helix A and Helix B is termed the AB loop. The 
structure of the second domain is designated by the prime 
symbol. All loops are colored grey, Helix A is yellow, Helix B is 
red and Helix C is blue. 
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the same N-terminus as the 14.5 kDa, as the latter evolved from the former, the 
16.5 kDa peptide fragments were then from residue 52 to residue 187 or 195. 
Similarly for the 12.9 kDa band, the probable peptide fragments were from 
residue 52 to residue 157, 158 or 164. These suggestions are summarized in 
Table VI. Comparable results were seen for the digestion of Spal57-368 and 
Spa52-368. Spa52-368 was slightly different in that it was first digested to 
-30 kDa fragments, presumably containing two sequence motifs, and then to 
14.2 kDa, presumably containing a single sequence motif 
When the digestion sites were examined in respect to their locations in 
the working structural model it was found that the initial digestion appears to 
occur within the loop region connecting helix A to helix B of the last domain of 
the peptide (Table VI). This corresponds to the -16 kDa fragment seen for 
both Spa52-262 and Spal57-368. By following the fragment size in this way it 
is seen that the two domain peptides Spa52-262 and Spal57-368, continue to 
be digested through the middle of helix A, producing -14. 5 kDa fragments, and 
finally to the beginning of helix A, producing -12.5 kDa fragments. The initial 
digestion in the AB loop corresponds to the - 30 kDa bands for the three 
domain peptide Spa52-368. Eventually these two domain sized fragment 
produced in the Spa52-368 digest succumbed to form peptides that correspond 
to the -16 kDa fragment and -14.5 kDa fragment seen in the Spa52-262 
digest. When all of the digests were considered the most prominent fragment 
was the -14. 5 kDa fragment. This suggested that the remaining structural 
domain gained significant stability, i.e., resistance to elastase digestion, from the 
presence of a remaining section of helix A. The presence of the 12. 9 kDa band 
suggested that the individual domain did have inherent structural stability and 
Table 6 - Characterization of Elastase Digestion Fragments 
Peptide Electrophoresis N-terminal Possible elastase Location of digestion sites 
Molecular Mass• sequenceb digestion sitesc within triple helical modeld 
{kDa} {residue#} {residues} 
Spa52-262 
(two domains) 16.5 (-140 AAst 157, 158 or 164 AB loop, 2nd domain 
14.5 (-123 AAs) SYHL (52-55) 170, 171, 174 or 179 middle helix A, 2nd domain 
12.9 (-109 AAs) 187 or 195 early helix A, 2nd domain 
Spal57-368 
(two domains) 16.0 (-136 AAs) 289, 293 or 297 AB loop, 2nd domain 
14.3 (-121 AAs) ALKF (157-160) 273, 277 or 280 early helix A, 2nd domain 
Spa52-368 
(three domains) 30.5 (-258 AAs) 305, 309 or 313 early helix B, 3rd domain 
28.3 (-240 AAs) 389, 293 or 296 AB loop, 3rd domain 
16.0 (-136 AAs) same as Spa52-262 AB loop, 2nd domain 
14.2 (-120 AAs) SYHL (52-55) same as Spa52-262 early helix A, 2nd domain 
a Obtained from 16 % SDS-PAGE data with 10 % uncertainties. 
b Amino acid sequence ofN-terminal residues. Residue numbers corresponding to those in a-spectrin were given in ( ). 
c The sites were identified according to the N-terminal residue, the number of AAs and elastase site specificity. 
d See section 4.2 for a description of the working structural model of a two-domain peptide. 
e The abbreviation AAs represents amino acid residues. 
u. 
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was thus partially independent. The elastase digestion results suggested greater 
C-terminal than N-terminal vulnerability in these peptides, since in all cases only 
the N-terminal complete domain was observed as the final digestion product. 
That is, Spa52-262 yielded only stable Spa52-156, not Spa157-262; 
Spa157-368 yielded only stable Spa157-262, not Spa263-368; and Spa52-
156 yielded only Spa52-156, not Spa157-262 or Spa263-368. A recent 
NMR solution structure of an individual spectrin domain shows that the C-
terminus of the single-domain, the AB loop and the N-terminus of the B helix, 
is the most disordered portion of the molecule (Pascual et al., 1997). This AB 
loop is also the most exposed portion of the structure, with the helices not as 
tightly packed at the C-terminus of the peptide as at the N-terminus (Fig. 4). 
This feature of less helical packing at the C-terminus of an individual structural 
domain was also suggested by the x-ray model (Yan et al., 1993). Both the x-
ray and NMR structures predict that position 28 of helix A is involved in an 
open salt bridge with helices C and B, separating it from them at the C-terminal 
end of the domain. Charged residues in this position are unusual as position 28 
is a "d" position in the heptad ("abcdefg") sequence of coiled coils, generally 
conserved as hydrophobic. The C-terminus of the NMR peptide may be 
disordered because it lacks the next domain and thus potential stabilizing 
interactions with that domain. Our working model showed a coiling of the 
helices which allowed for possible interactions between the C-terminus of the 
first domain with the N-terminus of the second domain (Fig. 5). Both the 
disorder found in the C-terminus of the NMR structure and the separation of 
helix A from helix B suggested by both the NMR and x-ray structures would 
seem to imply a vulnerable AB loop on the most C-terminus domain of a 
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particular peptide and also a vulnerable C-terminus, to elastase digestion, for 
this domain in general. The NMR and x-ray structures support the fact that 
digestion of our a-spectrin peptides apparently did not occur between two 
domains. Instead digestion was initiated at the C-terminus end of each peptide 
and then continued, eventually producing only the N-terminal domain of that 
peptide. In each case this N-terminal domain was most prominently present as 
the -14 kDa fragment, near but slightly larger than the expected size of 12.5 
kDa. This probably reflects the fact that the remaining, most N-terminal, 
domain gains significant structural stability from the presence of the first 10-20 
amino acid residues of the next domain's helix A and as a result region beyond 
the first 10-20 residues in helix A was the preferred digestion site. The working 
model described above suggested that this stability would come from 
interactions between the AB loop region of the first domain and the helix A' of 
the next (Fig. 5). The larger fragments were eventually all partially converted 
to the smaller fragments. Thus even though further digestion was possible, as 
seen by the appearance of the 12.5 kDa band in some of the digests, it was 
apparently not favored. 
These results suggested that the digestion began at the last domain of a 
peptide and continued towards the peptides N-terminal region, favoring 
intermittent fragments that contained a full domains plus a portion of helix A 
(-10-20 residues) of the next domain. The smallest fragments obtained (12.5 
kDa) corresponded to -106-amino-acid residues, thus the results also suggested 
that digestion beyond this point caused a substantial loss of structure and rapid 
digestion to smaller fragments that were not detectable by SDS-PAGE. These 
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results support the hypothesis that while the single-domain helical bundles are 
stable folded units but are not necessarily completely independent. 
6.3 Thermally Induced Unfolding by Fluorescence and CD 
Cooperativity is a measure of how much change occurs in one variable 
in response to a change in another variable. In other words, how sensitive is 
one variable with respect to another in protein unfolding. Cooperativity 
reduces intermediate states and favors either the native or the unfolded states. 
For example, a protein with high cooperativity, would remain essentially folded 
upon temperature increases until the temperature approaches the midpoint of 
unfolding temperature (Tm). Once the midpoint temperature was reached, the 
unfolding would occur rapidly. The sharpness of the transition would thus 
reflect the level of cooperativity of a transition. Thus the unfolding of various 
peptides can be monitored, with more (broader transitions) or less (sharper 
transitions) unfolding around the midpoint temperature representing a more or 
less cooperative transition, respectively. 
In our case we were measuring the sensitivity of protein unfolding, with 
respect to temperature, as monitored by changes in flourescence or CD222. 
Representative fluorescence and CD spectra of Spa.52-368 are shown (Fig. 6 & 
Fig. 7). The less change in temperature that was required to cause a large 
change in A.mean or CD222, the more cooperative the transition for the peptide. In 
both figure 6 and figure 7 the broader unfolding in LS buffer could be seen in 
the plots of fu. 
ASm , obtained from equation 6 was a measure of the cooperativity of 
the unfolding. A sharp transition with a steep AG dependence of temperature 
Figure 6 
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Fluorescence-monitored unfolding and fu of Spa.52-368. 
Fluorescence studies of thermal unfolding of Spa.52-368. 
Temperature-mediated unfolding was monitored by flourescence 
for Spa.52-368 in LS buffer (I) and in HS buffer (If!). A, The 
mean emission wavelength, A.mean, was used at each temperature. 
B, The fraction unfolded, fu, from equation 6 was used at each 
temperature. 
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CD-monitored unfolding and fu of Spa.52-368. CD studies of 
thermal unfolding of Spa.52-368. Temperature-mediated 
unfolding was monitored by CD for Spa.52-368 in LS buffer (D) 
and in HS buffer(•). A, The molar CD, 8222, was used at each 
temperature. B, The fraction unfolded, fu, from equation 6 was 
used at each temperature. 
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implies a high value of ASm. This could be seen as a phenomenon familiar to 
the Hill constant used to describe bound and unbound states. High values of 
the Hill constant represent sharp transitions, while low values represent broad 
transitions. In our system, lower values of ASm represented a broad unfolding 
transition, whereas large values of ASm represented a sharp transition. An 
example of this can be seen in the fu plots of Spa.52-368. When the unfolding 
curves were compared on the same scale the LS unfolding curves were more 
broad and had lower values of ASm than their respective HS unfolding curves, 
which were more sharp and had higher values of ASm. 
We suggest that high cooperativity (sharp transition) is the result of a 
large number of molecular interactions within the system studied. The unfolded 
state is presumed to involve fewer molecular interactions. Entropy is commonly 
thought of as a measure of disorder. Assuming the unfolded state of all peptides 
to be similar and to be highly disordered, we may estimate the degree of 
ordemess in a native state that is stabilized by molecular interactions. A native 
state with a larger number of molecular interactions would remain in an ordered 
state and exhibit more cooperative unfolding (high ASm) whereas a native state 
with less molecular interactions would remain in a less ordered structure which 
would exhibit less cooperative unfolding (low ASm). 
We used baseline correction to compensate for sloping regions either 
before (native state) or after (denatured state) of our CD and fluorescence 
unfolding curves (section 4 .19. 2). These types of corrections have been widely 
used (Lehrer & Stafford III, 1991; Eftink, 1994) and have been rationalized as 
due to intrinsic temperature dependence of the spectroscopic properties of the 
chormophores involved. Such behavior of the intrinsic fluorescence of the 
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indole chromophore of tryptophan in isolated form, 1.e. N-acetyl-
tryptophanamide has been observed and supports this treatment (Freifelder, 
1982). 
However, recently it has been shown that changes in the signal away 
from the transition region may reflect actual "pretransition" (Holtzer et al 1983) 
unfolding for local regions of the molecule (Holtzer & Holtzer, 1992; Lovett et 
al., 1996; Holtzer et al., 1997). However, this type of pretransition behaviour 
does not preclude a cooperative transition involving the bulk of the molecule. 
We were primarily interested in the larger cooperative transition. Thus we 
treated the smaller unfolding transition as baseline, and obtained slope factors 
for these regions. These slope factors thus may reflect spectral properties of the 
chromophores, or local pretransition unfolding. In any event, we do not ascribe 
any physical meaning to these parameters in this study, concentrating instead on 
the parameters involved in determining the larger, cooperative transition (Tm, 
~Sm). 
The Tm data for the single-domain peptides suggested salt-dependent 
unfolding, a property quite different from that of spectrin and the multiple-
domain peptides whose Tm values were essentially similar. The fluorescence Tm 
values for Spa263-368 seem to be high compared to the Tm values obtained 
from CD. An explanation for this may be found by examining the unfolding 
curves of this peptide for both fluorescence (Fig. 8) and CD (Fig. 9). The 
fluorescence unfolding curve for Spa263-368 was different from a typical 
unfolding curve in that it apparently contained an intermediate state. As the 
first transition was poorly defined these data were fit to the same two-state 
equation (6) used for all the data. In the fluorescence unfolding curve (Fig. SA) 
Figure 8 
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Fluorescence-monitored unfolding and fu of Spa.263-368. 
Fluorescence studies of thermal unfolding of Spa.263-368. 
Temperature-mediated unfolding was monitored by flourescence 
for Spa.263-368 in LS buffer (0) and in HS buffer(•). A, The 
mean emission wavelength, Amean, was used at each temperature. 
The fluorescence unfolding curve for Spa.263-368 was different 
from a typical unfolding curve in that it apparently contained an 
intermediate state. As the first transition was poorly defined 
these data were fit to the same two-state equation ( 6) used for 
all the data. B, The fraction unfolded, fu, from equation 6 was 
used at each temperature. 
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CD-monitored unfolding and fu of Spa263-368. CD studies 
of thermal unfolding of Spa263-368. Temperature-mediated 
unfolding was monitored by CD for Spa263-368 in LS buffer 
(D) and in HS buffer(•). A, The molar CD, 8222, was used at 
each temperature. When these curves were examined, in 
particular the LS curve, two transitions seemed to be evident but 
the relative contribution of the first to the entire unfolding curve 
was small. B, The fraction unfolded, fu, from equation 6 was 
used at each temperature. 
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it appears that approximately half of the unfolding, from -348 nm to -349 nm, 
occurs in the poorly defined transition. Thus the actual temperature for 50 % 
unfolded was not clear. Examination of the CD data showed that the 
intermediate state might also have occurred there (Fig. 9A), but in this instance 
the relative contribution to the entire unfolding curve was small. Thus the Tm 
values for Spa263-368 obtained from CD were considered to be more reliable. 
For Li Sm values, obtained from both CD and fluorescence data, it was 
found that the multiple-domain peptides and spectrin dimer exhibited sharper, 
more cooperative transitions in HS buffer relative to LS buffer (Table V). 
However, it was found that the single-domain peptides, in general, exhibited 
broader, less cooperative transitions for HS buffer relative to LS buffer. The 
HS/LS ratio of the LiSm values suggested that the salt effect on the multiple-
domain peptides was greater than the effect seen for the individual domains. 
Thus all our data suggested that peptides consisting of two or three motifs in 
tandem are more faithful in reflecting the properties of the spectrin dimer. 
The broader unfolding of spectrin in LS buffer that we have seen by CD 
and fluorescence has been observed in other earlier studies. Using optical 
rotary dispersion and calorimetry techniques Ralston & Dunbar (1979) detected 
broader thermal denaturation transitions for spectrin in 5 mM phosphate with 
no NaCl than for spectrin in 5 mM phosphate with 100 mM NaCl. It has 
similarly been seen by proton NMR that a wider unfolding range is found for 
the thermal denaturation of spectrin dimer in 1.5 mM phosphate buffer with no 
NaCl spectrin in 1.5 mM phosphate buffer with 150 mM NaCl (Begg et al., 
1994). The increased unfolding range in low salt is suggested to be the result of 
helical destabilization in the absence of charge screening (Begg et al., 1994). 
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They conclude that both configurational entropy and enthalpy play a role in the 
overall flexibility of spectrin (Begg et al., 1994). In another study it has been 
suggested that entropy drives the elasticity of spectrin, not the configurational 
entropy of flexible coils, but rather the entropy from the reversible dissociations 
of weak but specific intra/inter molecular contacts (Vertessy & Steck, 1989). 
Their findings also suggest that these weak interactions may arise from 
interdomain associations that could be broken, separating rather than denaturing 
the independently folded domains of spectrin (Vertessy & Steck, 1989). Our 
results on .::1Sm reflect an entropy difference for the transitions. A more 
cooperative transition corresponds to a high .::1Sm and thus to more molecular 
interactions. The multiple-domain peptides and spectrin showed a larger 
change in .::1Sm from HS to LS buffer, suggesting the multiple-domain peptides 
and spectrin dimer had more change in their number of interactions from HS to 
LS buffer than the single-domain peptides. Thus the results suggested that 
largely the interactions affected by the ionic strength were the domain-domain 
interactions, as the effect was seen to increase with increasing domain numbers 
(Fig. 3). Domain-domain interactions have also been implicated by our FTIR 
(increasing helicity and hydrogen-bond strength) and by our elastase digestion 
(no evidence of digestion at domain junctions) results for the multiple-domain 
peptides. Based on our results, we suggest that the location of these ionic 
strength mediated interactions may be between the C-terminal area of one 
domain, i.e., the AB loop region, and the N-terminal area of the following 
domain, i.e., the first 10-20 residues in helix A' (Fig. 5). 
CHAPTER VII 
CONCLUSIONS 
In Part I of this dissertation we found that the first amino acid residue of 
the first structural domain of a-spectrin was 52 (Ser) (Lusitani et al., 1994). 
In Parts II & III, we used the properly phased peptides of various 
lengths and studied them using FTIR, resistance to proteolytic digestion, CD 
and fluorescence to show that while the single-domain peptides were helical and 
protease resistant structures, the multiple-domain peptides were more helical, 
more resistant to proteolytic digestion and more true in their reflection of the 
ionic strength mediated changes of spectrin. 
The data presented in this dissertation provided evidence supporting the 
hypothesis that while the 106-amino-acid sequence motifs were able to form 
stable helical domains when properly phased, multiple-domain peptides were 
needed to fully reflect the properties of the spectrin dimer. The data also 
suggested that the additional properties displayed by the multiple-domain 
peptides were the result of the additional interactions that occurred between the 
structural domains when linked in tandem. The identification of the specific 
nature of these inter-domain interactions awaits direct experimental 
observations. 
74 
APPENDIX I 
The First a-Spectrin Structural Domain Begins with Serine 
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The First Human a-Spectrin Structural Domain Begins with 
Serine 
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SUMMARY 
The 106 amino acid sequence motifs of spectrin have been suggested to fold into 
s1able structural domains, consisting mostly of coiled coils of triple helices. With the advent 
of molecular biology and biophysical techniques, structural studies of these spectrin 106 
amino-acid structural domains became approachable. However one of the difficulties in 
such an approach is to determine the correct phasing of the structural domains, which may 
or may not coincide with the phasing of the sequence motifs. Proper identification of the 
domain phasing is vital to the construction of s1able spectrin domains for molecular studies. 
A previously published phasing shift for Drosophila a-spectrin indicated a downstream 
phase shift of 26 amino acids for the structural domain (Winograd, E., Hume, D., and 
Branton, D., 19<Jl, Proc. Natl. Acad. Sci. USA 88, 10788-10791). Using this phase shift, 
we prepared a recombinant spectrin peptide with the sequence from residue #49 to residue 
#155 of human erythrocyte a-spectrin, and found this peptide to be uns1able relative to other 
peptides that we prepared. Using several other recombinant a-spectrin peptides and 
following the protease digestion approach, we digested spectrin peptides with elas1ase and 
chymotrypsin and analyzed the amino acid sequence of the digestive products. We provide 
the first experimental evidence in identifying the first amino acid residue of the first spectrin 
domain in human erythrocyte a-spectrin as residue #52 (S). 
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Underlying 1he cytoplasmic surface of 1he human erythrocyte membrane is a dense, 
two-dimensional network of spectrin and o1her proteins 1hat provides support to 1he lipid 
bilayer, and maintains 1he erythrocyte flexibility (1). Spectrin, which is comprised of a-
and P-subunits, plays a critical role in maintaining 1he architecture and 1herefore 1he 
integrity of 1he red cell membrane. Many hereditary hemolytic anemias involve spectrin 
mutations (2-7). In addition, several o1her proteins, such as dystrophin, alpha-actinin, 
fibrin, etc. share many properties similar to 1hose of erythrocyte spectrin and are grouped 
as 1he spectrin super-family (1). Thus it is important to understand 1he structural properties 
of spectrin. However, little experimental information is available to describe 1he detailed 
three-dimensional structure of spectrin. Amino acid (8) and cDNA (9,10) sequence 
analyses of human erythrocyte spectrin (will be referred to as human spectrin hereafter; 
o1her types of spectrin will be clearly stated) reveal 1hat most parts of both subunits consist 
of homologous sequence motifs. Each motif consists of about 106 amino acids in length. 
There are 22 sequence motifs in tandem in 1he a-subunit and 17 sequence motifs in the P-
subunit. These sequence motifs have been suggested to fold into stable structural domains, 
consisting mostly of coiled coils of triple helices (11,12). With the advent of molecular 
biology and biophysical techniques, structural studies of these spectrin 106 amino-acid 
structural domains (spectrin domains) became approachable. Recently, the X-ray structure 
of a homodimer of a 106-amino acid fragment in segment 14 of Drosophilia a-spectrin has 
been published (13). However one of the difficulties in such an approach is to determine 
the correct phasing of the structural domains, which may or may not coincide with the 
phasing of the sequence motifs. 
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Winograd et al. (14) provided experimental evidence from Drosophila a-spectrin 
fragments to suggest a downstream phase shift of 26 amino acids for the structural domain 
such that the first amino acid in a folded unit is residue #26 in the 106-residue sequence 
motif. Assuming human a-spectrin has the same phase-shift as Drosophila a-spectrin, the 
first amino acid at 1he N-terminal end of the first structural domain (AAl) would be residue 
#49 (L), since residue #24 (I) is the first amino acid of the first sequence motif in human 
a-spectrin (9). Based on information obtained from protease protection analysis (12), 
Speicher et al. suggest that structural domains begin and end around residue #30 of the 
sequence motif of a-spectrin (15). These phase-shifts have been used to construct structural 
models or recombinant peptides. The Winograd phase-shift (14) was used to construct 
recombinant peptides either of a-spectrin for X-ray studies (13) or for folding studies (16), 
or of P-spectrin for supra-motif studies (17). The phase-shift of dystrophin was compared 
with Winograd's phase-shift in spectrin and was found to be different by an upstream-shift 
of 9 amino acids (18). The Speicher phase-shift (12) was used to construct recombinant 
peptides for spectrin tetramer binding site studies (15). Kennedy et al. stated that the 
phasing of the structural domain in P-spectrin is shifted approximately 20 to 30 residues 
toward the COOH terminus compared with the phasing of the sequence motifs (19). 
Not only do different published results suggest different amino acids as AA 1 for the 
structural domain but different numbering systems for the amino acids in the spectrin 
sequence are also used. Before the publication of a-spectrin cDNA results, E was residue 
#1 according to Speicher and Marchesi (20). The human spectrin cDNA results detected 
six additional amino acids located upstream of E to give MEQFPKE as the first seven amino 
80 
acids in a-spectrin (9). Thus residue #1 (E) in the previous numbering system (20) is now 
residue #7 in the cDNA numbering system (9) Both numbering systems are used in the 
literature, though not necessarily clearly referenced, for all types of spectrin. Parry and 
coworkers (21) identify the starting position of the first structural motif as residue 46, using 
the numbering system of Speicher and Marchesi (20). Yan and coworkers (13) in their 
work on segment 14 of Drosophila a-spectrin use the cDNA numbering system. We follow 
the cDNA numbering system in this report (Fig. 1). 
Using several recombinant human a-spectrin peptides and following the protease 
digestion approach used by Winograd and coworkers (14), we provide the first 
experimental evidence in identifying the first amino acid residue of the first spectrin domain 
in a-spectrin. Proper identification of domain phasing is vital to the construction of stable 
spectrin domains for molecular studies. Our results show that the first spectrin structural 
domain starts with residue #52 (S) (Fig. 1). 
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MATERIAL AND METHODS 
Spectrin Recombinant Peptides 
The cDNA clone a.3 that contains the N-terminal region of the a-subunit (9) a 
generous gift of Dr. B.G. Forget, Yale University School of Medicine, New Haven, CT, 
was linearized with Sacll.and used as a template. Oligonucleotide primer containing 
sequence corresponding to residues #1 through #9 of a.-spectrin, in a sense orientation, and 
primer containing sequence corresponding to residues #159 through #167, in an anti-sense 
orientation, were synthesized by National Biosciences (Plymouth, MN) and used to make 
the spectrin construct of a peptide with the sequence of a.-spectrin from residue #1 to 
residue #167 (Spa.1-167). 1 The published a.-spectrin sequence (9) was used. Similarly, 
spectrin constructs of Spa.49-155 and Spa.49-167 were also prepared. Some of the 
oligonucleotide primers were synthesized by the Wells Center Oligonucleotide Synthesizer 
Laboratory. The spectrin constructs were ligated into the BamHI and EcoRI sites of the 
glutathione S-transferase (GST) expression vector pGEX-2T (Pharmacia, Piscataway, NJ). 
These ligations were in-frame with the GST protein. The pGEX-2T vector contains a 
thrombin cleavage site between GST and the inserted gene, i.e., spectrin construct. The 
spectrin peptides were located immediately following the thrombin cleavage site. The 
expression of fusion protein was under the control of a tac promoter. Thus, high, inducible 
levels of fusion proteins were produced. 
The overproduced fusion protein (GST-thrombin cleavage site-spectrin peptides) 
was recovered from bacterial lysate and passed over a glutathione affinity column (e.g., 
glutathione-Sepharose 4B from Pharmacia), using published methods (22). The column, 
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with the bound fusion protein, was extensively washed, followed by elution with buffer 
containing fresh glutathione. The spectrin peptide was cleaved from the GST by 
immobilired thrombin gel (CalBiochem, San Diego, CA) and eluted with GST and residual 
uncleaved fusion protein from the gel. The mixture was passed over the glutathione affinity 
column again to remove GST and residual fusion protein to give relatively pure spectrin 
peptides. If necessary, the peptides were further purified by fast protein liquid 
chromatography (FPLC) with a Mono Q column (Pharmacia), using 40 mM Tris at pH 7 .5 
and an NaCl gradient. 
Enzyme Dj~stion and Peptide Sequencin~ 
Elastase from porcine pancreas (Sigma) in 5 mM Tris at pH 5.0 was mixed with 
a spectrin peptide at a weight ratio of 1:12.5, in 50 mM Tris at pH 8.8 and room 
temperature. Samples were taken from the mixture at various time points for gel 
electrophoresis analysis. Similarly, chymotrypsin from bovine pancreas (Sigma) in 1 mM 
HCl was mixed with spectrin peptide at a weight ratio of 1:400 (14), in 40 mM Tris with 
125 mM NaCl at pH 7.5 and room temperature. 16 % polyacrylamide gel electrophoresis 
was performed using electrophoresis buffer containing 0.5 % SOS. Low range protein 
molecular weight standards (Gibco BRL, Gaithersburg, MD) at 43.0, 29.0, 18.4, 14.3, 6.2 
and 3.0 kDa were used to guide the molecular mass calculation. For amino acid sequence 
analysis, polyvinylidene diflouride membranes (Applied Biosystems, Foster City, CA) were 
used for electroblotting. The amino acid sequencing of the digestive product was done by 
the University of Illinois Biotechnology Center. 
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RESULTS AND DISCUSSION 
Using Winograd's downstream phase-shift of 26 amino acids, we designed Spa49-
155, a peptide with 107 amino acid residues and with AAl at #49, to be a peptide that 
included the first stable structural domain of human a-spectrin. However, Spa49-155 was 
found to be unstable when compared to the other Spa-peptides that will be discussed below. 
The electrophoretic gel of Spa49-155 purified by FPLC techniques exhibited several bands, 
with the predominating band at 12.7 kDa and two minor bands at about 9.8 and 8.7 kDa 
(Lane 1, Fig 2A). The molecular mass for Spa49-155 calculated from the sequence was 
12. 7 kDa. Thus, we believe that the major band was that of Spa49-155 and the minor 
bands were from degradation products of Spa49-155. In the presence of elastase, at a 
weight ratio of 1: 12.5, Spa49-155 was quickly digested into smaller fragments. At t = 10 
min, bands below 12. 7 kDa appeared at low intensities with the concurrent decrease in the 
in~nsity of the 12.7 kDa band (Lane 2). As the digestion reaction with elastase proceeded 
further, a steady decrease in the intensity of the 12.7 kDa band and an increase in the 
intensities of the smaller bands were observed (Lanes 3, 5, 6 and 7). At t = 60 min, the 
band at 12. 7 kDa was no longer detectable but faint bands below 12. 7 kDa were visible 
(Lane 8). In contrast, under similar conditions, the peptide Spa49-167 was quite stable. 
Spa49-167, with a molecular mass of 14.2 kDa calculated from the sequence, appeared as 
a single band at 13.2 kDa on the gel (Lane 1, Fig. 2B). After 60 min digestion with elastase 
under the cotxlitions listed above for Spa49-155, the Spa49-167 digestion product appeared 
as a single band at 13.2 kDa (Lane 2). This band persisted at t = 2 hr (Lane 3). The 
intensity of this band decreased at t = 3 hr (Lane 5), appeared as only a faint band at t = 
84 
4 hr (Lane 6) and finally became not detectable at t = 5 hr (Lane 7). Thus these digestion 
results suggest Spa49-167 is folded into a more stable configuration than Spa49-155 and the 
folded structure resists elastase digestion. The amino acid residues beyond #155 in Spa49-
167 provide elements to fold the peptide into a more stable structure. 
The FPLC purified peptide Spal-167, with a molecular mass of 19.9 k.Da 
calculated from the sequence, appeared as a single band at about 21.0 k.Da (Lane 2, Fig. 
3A). Elastase digestion of Spal-167 (at weight ratio of 1: 12.5) resulted in two bands at 
16.0 and 12.8 k.Da at t = 90 min. These two bands persisted in the digestion mixture at t 
= 4 hr (Lane 3, Fig 3A). The band intensity became undetectable at t = 5 hr (not shown). 
These data suggested that the digestion products were very stable peptides when compared 
with Spa49-155, and had similar stability to the digestion product of Spa49-167, which also 
withstood elastase digestion beyond 4 hr. 
The N-terminal sequence analysis of the 12.8 k.Da fragment was found to be 
EDSYHLQVFK, which aligned perfectly with #50- #59 in the a-spectrin sequence (Fig 1). 
The elastase cleavage sites around this region of a-spectrin consist of #46 (G), #49 (L), and 
#52 (S), and cleavage sites at the C-terminal end of the peptide consist of #151 (G), #154 
(L), #155 (L), #157 (A), #158 (L) and #164 (V). We suggest that elastase cleaved at #49 
(L) and at #157 (A) to give the peptide Spa50-157, which has a calculated molecular mass 
of 12.8 k.Da. The first amino acid at the N-terminus of this digestion product was clearly 
#50 (E), as indicated by the sequence analysis data. However, the last amino acid at the C-
terminal end was less certain and was suggested by matching gel electrophoresis molecular 
masses with calculated molecular masses. It was also possible that the digestion product 
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was Spa50-154, Spa50-155 or Spa50-158, with calculated molecular masses of 12.5, 12.6 
or 12.9 kDa, respectively. Thus the N-terminal sequence analysis of the elastase digestion 
product (12.8 kDa) of Spal-167 suggests that the AAl is either #50, 51or52. If AAl is 
#50 or #51, then the first stable structural domain of human a-spectrin is Spa50-154 or 
Spa51-155, since the first motif of a - spectrin is comprised of 105 amino acid residues 
(20), with a molecular mass of 12.5 or 12.6 kDa, respectively. Howev.er, we found that 
the elastase digestion product of Spa49-155, a peptide that encompasses both #50-154 and 
#51-155, did not produce any peptides with stability similar to those found in the digestion 
products of the other peptides that we studied. This piece of evidence suggested that the C-
terminal residue of the first structural domain was beyond #155. We conclude that the C-
terminal residue is #156 and AAl is #52, giving a stable structural domain of Spa52-156. 
Based on this conclusion, we suggest that Spal-167 contains a fully folded structural domain 
which is able to resist elastase digestion. Elastase will only digest Spal-167 at sites prior 
to #52 and after #156 to give the digestion product Spa50-157, with a molecular mass of 
12.8 kDa. As discussed above, the digestion product of Spal-167 appeared as a band at 
12.8 kDa (Lane 3, Fig 3A). 
The N-terminal sequence analysis of the 16.0 kDa fragment was found to be 
ETAEEIQERR, which aligned perfectly with #19 - #28 in the a-spectrin sequence. The 
elastase cleavage sites around this region of a-spectrin consist of #17 (V), #18 (L) and #21 
(A). The possible peptides were Spal9-154, Spal9-155, Spal9-157 or Spal9-158, with 
calculated molecular masses of 16.3, 16.4, 16.6 or 16.7 kDa, respectively. We suggest that 
the peptide is either Spal9-157 or Spal9-158. This peptide probably contains Spal9-51, 
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the so called "helix 3" (12), which is also called "helix A" (11), plus the first stable 
structural domain Spa52-156 and residue #157. 
We also performed chymotrypsin digestion to obtain independent digestion products 
from Spal-167. Chymotrypsin has cleavage sites different from those of elastase. After 
90 min chymotrypsin digestion (at a weight ratio of 1:400), the single band of Spal-167 at 
21.0 kDa (Lane 2, Fig. 3B) resulted in 6 bands at or below 21.0 kDa, with the smallest one 
at about 14.5 kDa (Lane 3). The top band at 21.0 kDa was assumed to be the undigested 
Spal-167, while the other 5 were chymotrypsin digestion products of Spal-167. The N-
terminal sequence analysis of the smallest band at 14.5 kDa revealed an amino acid 
sequence of KERV AE, which aligned perfectly with #39 (K) - #44 (E) of a-spectrin. The 
chymotrypsin cleavage sites around this region consisted of #35 (Y), #38 (F) and #53 (Y), 
and the cleavage sites at the C-terminal end of this peptide consisted of #140 (W), #160 (F) 
and #163 (Y). We suggested that the chymotrypsin digestion product at 14.5 kDa was 
Spa39-160, which has a calculated molecular mass of 14.5 kDa. It is also possible that the 
digestion product was Spa39-163, with a calculated molecular mass of 14.9 kDa. The 
chymotrypsin digestion data indicate that AAl is between residues #39 and #53, which 
supports the conclusion obtained from the elastase digestion data to indicate that AAl is #52. 
Thus our experimental results indicate that the first amino acid in human a-spectrin 
structural domain is #52 (S), which corresponds to a downstream phase-shift of 29 amino 
acid residues from the sequence motif reported by Speicher and Marchesi (20). 
It is interesting to note that when we carefully studied the sequences published in 
literature on works that reportedly use the Winograd phase-shift (13, 16, 17) to prepare 
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recombinant peptides, we found that MacDonald et al. (16) had used a phase-shift 
corresponding #49 (L) as AAl, whereas Byers et al. (17) and Yan et al. (13) had used a 
phase-shift corresponding #52 (S). We had mentioned earlier that in a modeling study, 
Parry et al. (21) identify the starting position of the first structural motif as residue 46, with 
their numbering system according to Speicher and Marchesi (20). Since this numbering 
system starts with amino acid #7 (E) as #1, this modeling study has also placed AAl as #52. 
Thus, AAl being #52 might have been suggested earlier without experimental evidence in 
the literature. However, since the phase-shifts were not clearly stated as #52(S) in some 
of these works (13,17), different phase-shifts have been used to prepare recombinant 
spectrin peptides (16, 18, 19). 
Our experimental studies show that amino acids #52 - #156 in human a.-spectrin are 
folded as a stable structural domain. Preparation of this and related peptides for biophysical 
studies will provide us with detailed structural information of spectrin. 
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FOOTNOTE 
1Spal-167 - a peptide wi1h 1he sequence of a-spectrin from residue #1 to residue #167; GST 
- gluta1hione S-transferase; FPLC - fast protein liquid chromatography; AAl - 1he first 
amino acid at 1he N-terminal end of 1he first structural domain. 
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FIGURE LEGENDS 
Fig. 1. Amino Acid Sequence of Human Erythrocyte a-Spectrin from Residue #1 to 
#167. The cDNA numbering system is shown and used throughout this 
presentation. Elastase ( l) and chymotrypsin (*) recognition sites are included. 
Underlined arrows/asterisks indicate sites of elastase cleavage as reported here. 
The amino acid residues in the first a-spectrin structural domain are shaded. 
Fig. 2. SDS-PAGE (16 % gel) of elastase digestion products of a-spectrin peptides, 
stained with Coomassie Brilliant Blue. 
A: Lane 1, FPLC purified Spa49-155 (no elastase present); Lane 2, 10 min after 
the introduction of elastase, at a peptide to enzyme weight ratio of 12.5: 1; Lane 
3, 20 min; Lane 5, 30 min; Lane 6, 40 min; Lane 7, 50 min; and Lane 8, 60 min. 
Lane 4, molecular weight standards. 
B: Lane 1, FPLC purified Spa49-167 (no elastase present); Lane 2, 1 hr; Lane 3, 
2 hr; Lane 5, 3 hr; Lane 6, 4 hr; and Lane 7, 5 hr. Lane 4, molecular weight 
standards. 
Fig. 3. SDS-PAGE (16% gel) of proteolytic digestion of Spal-167, stained with 
Coomassie Brilliant Blue. 
A: Elastase digestion of Spal-167. Lane 1, molecular weight Standards; Lane 2, 
Spal-167 (no elastase present); Lane 3, 4 hr after the introduction of elastase, at 
a peptide to enzyme weight ratio of 12.5 to 1. Bands at 16.0 and 12.8 kDa were 
used for amino acid sequence analysis. 
B: Chymotrypsin Digestion of Spal-167. Lane 1, molecular weight standards; 
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Lane 2, Spal-167 (no chymotrypsin); Lane 3, 90 min after the introduction of 
chymotrypsin at a peptide to enzyme weight ratio of 400: 1. Band at 14 .5 was used 
for N-terminal amino acid sequence analysis. 
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(c) SUMMARY 
The primary sequence of human erythrocyte spectrin contains repetitive 
homologous sequence motifs of approximately 106 amino acids with 22 such motifs 
in the a-subunit and 17 in the P-subunit. These homologous sequence motifs have 
been proposed to form domains with a triple helical bundle type structure (Speicher, 
D.W. and Marchesi, V.T. (1984) Nature 311, 177-180; Parry, D.A.D., Dixon, T.W. 
and Cohen, C. (1992) Biophys. J. 61, 858-867). In this study, we show that these 
sequence motifs, while they do form compact proteolytically resistant units, are not 
completely independent. Peptides composed of two or three such motifs in tandem 
are substantially more stable than peptides composed of a single motif, as measured 
by proteolysis or by fluorescence or circular dichroism studies of urea or thermal 
denaturation. Circular dichroism and infra-red spectroscopy measurements also 
indicate that these larger, more stable peptides exhibit greater secondary structure. 
In these respects, the peptides with tandem sequence motifs are more similar to 
intact spectrin than the peptide with a single sequence motif Thus, we conclude 
that peptides with more than one sequence motif model spectrin more adequately 
than the peptides with one sequence motif, and that these sequence motifs are not 
completely independent domains. 
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( d) INTRODUCTION 
Human erythrocytes contain a dense, two-dimensional network of spectrin 
and other proteins that provides support to the lipid bilayer and maintains 
erythrocyte deformability (1). Spectrin, comprised of a- and P-subunits, plays a 
critical role in maintaining the architecture and therefore the integrity of the red cell 
membrane. Many hereditary hemolytic anemias involve spectrin mutations (2-4). 
Thus, it is important to understand the structural properties of spectrin. The bulk 
(about 90 % ) of the primary structure of spectrin is comprised of repetitive 
homologous units of approximately 106 amino acids in length. Several other 
proteins, including brain spectrin (fodrin), dystrophin, and a-actinin, also have 
similar repetitive amino-acid units in their sequences and are known as the spectrin 
super-family (5). 
A triple helical bundle model has been suggested for the 106-amino-acid 
sequence motif in which the three helices are aligned side by side, with the first and 
third parallel and the intervening second helix antiparallel (6-8). X-ray diffraction 
studies of one such sequence motif unit from a non-erythroid spectrin support this 
model (9). In these X-ray studies, the peptide used was found to form a homodimer 
containing two triple helical structures, in which two of the three helices are 
contributed by one monomer and the remaining helix by the other monomer. It is 
thought that this peculiar arrangement may be an artifact of crystallization, and the 
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true structure of a single unit may be similar to the earlier suggested triple helical 
bundle with a zigzag arrangement of the helices (9, 10). This arrangement aligns the 
amino- and carboxyl- terminal residues at opposite ends of this triple helical bundle, 
and thus sequential motifs are thought to be linked in tandem in intact spectrin, 
producing a very long rod shaped molecule, approximately 100 nm in length, as seen 
by electron microscopy (11). 
Circular dichroism (CD) (12, 13) and Fourier transform infra-red (FTIR) 
( 14) studies of intact spectrin corroborate this model, indicating that spectrin 
consists of a large proportion of a-helix. However, little experimental information 
is available on the molecular structure of intact spectrin, in part due to its large size 
and its structural flexibility which makes nuclear magnetic resonance or X-ray 
studies difficult. Recombinant DNA methods have been used to prepare more 
t.ractable fragments of spectrin which may serve as models for spectrin, as in the 
aforementioned X-ray studies. However, the question of which fragment of spectrin 
to choose as an appropriate model is important. The two factors that need to be 
considered are phase and length of the fragment. 
The issue of appropriate phase results from the fact that the homologous 
sequences are joined in tandem with no obvious intervening delimiting sequences, 
making the initial residue of the folded domains unclear. The start of the sequence 
for an appropriate structural unit may not be assumed to coincide with the start of 
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the homologous sequence motif in the primary sequence, especially since the onset 
of the repetitive homologous sequence occurs with different phases in the amino 
acid sequence of different members of the spectrin family of proteins. 
We have used limited proteolysis to identify Sers 2 as the first residue of the 
first structural domain of human erythrocyte a-spectrin (15). This places the start 
of the first structural domain after the onset of the homologous sequence motif ( 6), 
indicating that there is a fractional motif at the amino terminus in this protein. 
Proteolysis experiments to delimit compact structural domains have also been done 
by others on invertebrate spectrin (16), as well as on actinin (17) and dystrophin 
(18). These studies have shown that the domain boundaries in these spectrin or 
spectrin-like proteins are similar, and may be identified by a pair of highly conserved 
tryptophan residues at positions 17 and 90 into the domain. 
The issue of length is another matter. The proteolysis work has clearly 
shown that a single sequence motif folds into a compact structure, but does this 
structure capture the properties of the corresponding region in intact spectrin, or are 
larger fragments necessary? In order to assess this question, more detailed 
examination of the proteins involved are necessary. We have addressed this issue 
by producing peptides spanning the first three homologous sequence motifs of 
human erythrocyte spectrin, both in isolation and in tandem, and comparing them to 
intact spectrin in terms of their stability and spectral properties. We found that 
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peptides containing more than one sequence motif were notably more stable to 
chemical and thermal denaturation, both thermodynamically and kinetically, and that 
the properties were more similar to those of spectrin. Our results suggest that a 
single 106-amino-acid unit of a-spectrin folds into helical bundles as a stable 
structural unit but does not fully capture the structural and unfolding properties of 
intact spectrin. However, peptides encompassing multiple 106-amino-acid sequence 
motifs are much more faithful in capturing the properties of intact spectrin. 
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( e) EXPERIMENT AL PROCEDURES 
Purification of intact spectrin from human red blood cells was carried out as 
before (19, 20). 
For a-spectrin fragments, genes were constructed producing six different 
fragments: Spa52-156t, Spa157-262, Spa263-368, Spa52-262, Spa157-368 and 
Spa52-368. The peptide Spa52-156 encoded the sequence of human erythroid 
a-spectrin (21) from residue Ser52 to residue Arg156, while the other peptides 
spanned regions in spectrin indicated by the numerals in their names. These peptides 
were expressed as fusion proteins with glutathione S-transferase in E. coli and 
released by thrombin cleavage, as previously described (15). 
Briefly, cDNA encoding the N-terminal region of the a-subunit of human 
erythrocyte spectrin (clone a3, a generous gift of Dr. B.G. Forget, Yale University 
School ofMedicine, New Haven, CT) was used as a template for PCR amplification 
of the spectrin gene fragments. Restriction endonuclease sites were incorporated 
into the primers to facilitate subcloning manipulations and incorporation into the 
expression vector, pGEX-2T (Pharmacia, Piscataway, NJ). For example, the 
sequence of the 5' primer used in the synthesis of Spa52-156 was [5'-
cttaaatccTCCTATCACTTAca -3'], with upper case letters for the homologous 
region encoding for the N-terminal amino acids SYHL. Lower case letters denoted 
non-homologous nucleotides, while those underlined denoted the EcoRI site. The 
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sequence of the 3' primer was [5'- cggiaattccta CCGCAGCAACTG -3'], with 
upper case letters for the homologous region encoding for the C-terminal amino 
acids QLLR. Those underlined denoted the Bamm site. All other peptides were 
prepared with similar primer designs. Amplified fragments were initially subcloned 
into a PCR cloning vector (pCRScript; Stratagene; La Jolla, CA) and were then 
excised with appropriate restriction enzymes (Bamlfl and EcoRI) and cloned into 
pGEX-2T. 
These peptides were designed to start with proper phasing for folding 
domains (15). Thus, Spa52-156, Spal57-262 and Spa263-368 consisted of the 
first, second and third, respectively, single structural domains of a-spectrin. Other 
peptides contained two (Spa52-262 and Spal57-368) or three {Spa52-368) such 
structural domains. The two highly conserved tryptophan residues were at positions 
17 and 90 in all six peptides. 
Fusion proteins isolated from E. coli were treated with either thrombin resin 
(15) or soluble thrombin (Enzyme Research Laboratories, South Bend, IN) to 
release the spectrin peptides. The use of soluble thrombin involved incubation with 
thrombin {lU/mg fusion protein) at 37 °C for about 3 h, until digestion was 
complete as judged by SDS-P AGE. Thrombin was then inactivated by addition of 
phenylmethyl-sulfonylfluoride (Aldrich; Milwaukee, WI) to 1 mM. 
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The rest of the purification procedure was as previously described, except 
that the buffer pH for the monoQ FPLC (Pharmacia) purification step was changed 
to pH 8.1, which moved the elution position for the spectrin peptides to 
approximately 125 mM NaCl. The spectrin peptides were then further purified, if 
necessary, by molecular sieve chromatography over a G-75 (Pharmacia) column in 
5 mM phosphate buffer containing 150 mMNaCl at pH 7.4 (PBS). 
Peptide purity was confirmed by SDS-PAGE (12 - 16 %). Peptides were 
also checked by amino-terminal sequencing (Biocore Facility, University of Notre 
Dame, South Bend, IN), and mass spectrometry using time of flight-matrix assisted 
laser desorption ionization (TOF-MALDI) methods (Wistar Mass 
Spectrometry/Sequencing Facility; Philadelphia, PA). 
To determine whether the peptides formed aggregates in PBS solution, the 
molecular masses of the peptides in solution, at 0.1 - 1 mg/ml concentrations, were 
determined at 35 °C with an absolute molecular mass determination instrument 
(PD2000, Precision Detectors, Inc.; Amherst, MA). The intensity oflight scattered 
at 15 and 90 degrees from a 630 nm laser and the refractive index were monitored 
as the peptide under investigation eluted from a G-7 5 column. Data were analyzed 
to give solution molecular mass distribution profiles (22). The intensity of the 
scattered light is proportional to the molecular mass of the molecules in solution, 
with the following relationship: IJlo = 21t2(n(5n/5c))2/NAA. 4r2 * (l+cos28) * M * c 
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, where Io and 16 are the intensities of light with wavelength A scattered at angles 0 
and e degrees; n is the refractive index of the pure solvent; on/oc is the change in 
refractive index of solutions of the molecule of interest with respect to its 
concentration, c; NA is Avogadro's number; r is the distance between scattering 
center and the detector; and M is the molecular mass {22). With the concentration 
c determined from the refractive index signal (c=~n*oc/on), the molecular mass was 
calculated from IJio. The above relation assumes ideal solution behavior. For real 
solutions, this exact proportionality breaks down, and accurate determinations 
necessitate extrapolation to c = 0. The use of light scattering in conjunction with 
chromatography facilitates this extrapolation, as light scattering and refractive index 
signals are monitored during the elution of the molecules from the column, during 
which the concentration varied. 
The precise protein concentrations were determined with absorbance values 
at 280 nm (Azso), using extinction coefficients determined from the primary sequence 
by the ProtParam tool on a molecular biology server (http://expasy.hcuge.ch 
/www/expasy-top.html). Due to the large size of the spectrin molecule, absorbance 
measurements of spectrin solutions were complicated by scattering. In order to 
compensate for this effect, the contribution of absorption due to scattering was 
estimated by both the absorbance at 320 and 350 nm (where the absence of 
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electronic chromophores was presumed) and the dependence of scattering intensity 
on wavelength (23). This usually resulted in about a 3 % correction. 
Elastase digestion was performed as before (15). Briefly, the peptides, at 
approximately 1 mg/ml in 50 mM Tris at pH 8. 7, were incubated with elastase at 
20 °C (mass ratio of peptide to elastase was about 1:250), and aliquots were 
analyzed by SDS-PAGE at 0.5 h intervals for 2 hand then every hour for the next 
five hours. Stained gels were dried and digitized with a Scanman II scanner 
(Logitech; Freemont, CA) at a resolution of 400 dpi. The protein content of 
individual bands in each lane was determined by integration of digitized images of 
band intensities, using the SigmaGel program (Jandel Scientific Software; San 
Raphael, CA). Time constants for the disappearance of each peptide ( "tg) were 
determined by fitting the initial band intensity (10) and the remaining band intensity 
(I), at each time point (t), to a simple exponential decay curve I/10 =exp (-ti\). 
Molecular masses of the initial peptides, as well as the degradation products were 
measured by comparison to standards of known molecular mass. 
FTIR spectra were collected as previously described (14). Briefly, samples 
at - 30 mg/ml in 5 mM sodium phosphate buffer at pH 7.4 were used. Spectra were 
collected using a BioRad FTS 410 FTIR spectrophotometer and a cell path length 
of6 µm. An interferogram with a size of 4,600 points, corresponding to the 400 to 
4,000 cm·1 region, was acquired for 1,024 scans. Buffer and atmosphere (for water 
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vapor) blanks were subtracted from each sample to yield a flat baseline in the 1, 750 
to 2,000 cm·1 region. Center frequencies of the amide I bands were determined by 
second derivative maxima. 
CD measurements on samples at about 1.5 mM residues (A280 - 0.2) were 
obtained with a JASCO 710 CD spectrometer, using a thermostated (water 
jacketed) cell with 0.1 cm path length. Under our buffer conditions (PBS), spectra 
were limited to wavelengths greater than 190 nm. Spectra were obtained at 0.5 nm 
resolution from 190 to 300 nm, using subtraction of a buffer blank to smooth the 
baseline. The molar ellipticity at 222 nm, <1> 222 (degree cm2 dmol-1), was calculated. 
In determining a-helical contents for each peptide from CD data, the more 
usual deconvolution procedures that yield percentage compositions of a-helix, P-
sheet, turns and random coil (24, 25) were not used. These methods rely on a basis 
set of proteins composed of known percentages of the secondary structural elements 
and most accurately predict structures of proteins with similar structural elements. 
Proteins containing structures of coiled coils were generally not included in the basis 
set. In addition, the specific alignment of the a-helices with respect to each other 
in spectrin is not random (being exclusively parallel or antiparallel), a situation that 
is known to distort CD spectra (24), further complicating the analysis. Thus, we 
followed the method used for dystrophin, which has a structure similar to spectrin, 
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by using a value of cl>222 = -36,000 degree cm2 dmo1·1 to represent peptides with 100 
% a-helical structure (18). 
Urea denaturation of the peptides was measured by fluorescence 
spectrometry, using a Hitachi F-2000 fluorescence spectrophotometer at 20 °C with 
a 1 cm path length cuvette. Samples with A280 - 0.02 in PBS were incubated with 
urea at different concentrations (0 - 6 M) and allowed to equilibrate overnight (16 -
20 h). Using an excitation wavelength of278 nm, emission spectra from 315 to 385 
nm for each sample were collected. The values of the mean emission wavelength, 
A.mean defined as ~an = ~ I /~ J A.·1 (26, 27), were calculated from values of 
intensity at each wavelength A. (IJ for each spectrum and used to monitor unfolding. 
This parameter is a more suitable measure of unfolding than either simple intensity 
measurements at a particular wavelength (28), or a ratio of intensities at two 
wavelengths (29). Since A.mean incorporates the information in the whole emission 
spectra, it is less noisy, and more sensitive to changes in any region of the spectra 
than those obtained with other generally used methods. The use of this parameter 
also eliminates the need to single out any particular wavelength for intensity 
measurements. This is important in multi-step transitions, as certain wavelengths 
may emphasize one transition over the others and give an incomplete view of the 
unfolding transition. Most of the A.mean denaturation data were fit to a single-
transition two-state model, in which the free energy change of unfolding (LlG) was 
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linearly proportional to urea concentration (U), according to the following equation. 
To simplify the fitted equation, AG' was used and was defined as AG/RT. 
A =A + AA (e·AG'.(1-U/[UreaJ...))/{l +e·AG'.(l-U/[UreaJ...)) where A is mean, U mean,O mean , mean,O 
the A.mean value without urea and Amcan,u is the A.mean value at each urea concentration 
U. Parameters to be fitted from the experimental points were AG' 0, [Urea]mid' Amean,o 
and AA. mean· Some data clearly showed two transitions, implying the presence of 
three states (native, intermediate and denatured states). These data were then fitted 
to a three-state model, which was extended from the two-state model. 
In order to determine if the samples were indeed at equilibrium, rates at 
which peptides were denatured by 4 M urea (a minimal urea concentration that 
sufficiently unfolded all of our peptides) were examined. In these experiments, a 
200 µL aliquot of protein sample was rapidly added, at 20 °C with stirring, to 
1,800 µL of 4.44 M urea in PBS to yield a final urea concentration of 4 M. 
Emission spectra were taken as above at intervals, from 1 min to 250 min. The data 
were fit to a multi-exponential decay curve. The choice of either single, bi- or 
higher exponential was made by examining the x2 values for the fitted curves. The 
model with the lowest x2 value was chosen, and in all cases was a bi-exponential 
decay, 
Fluorescence time constants ( 'tn and 'tn ) were obtained from these curve fits. 
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Denaturation by urea was also monitored by CD. In this experiment, peptide 
samples with a final A280 - 0.4 were made up to various concentrations of urea in the 
range 0 - 6 M and allowed to equilibrate overnight. «1>222 was measured for each 
sample at 20 °C. 
Thermal denaturation was examined by scanning the temperature upward 
from 5 to 75 °C, at 1 °C/min, and monitoring «1>222• The temperature of the 
maximum value of d«l> 22/dT for each peptide was reported as Tm. 
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(f) RESULTS 
All six spectrin peptides were purified to a high degree of purity. For 
example, gel scan analysis ofSDS-PAGE ofSpo:52-156, Spo:52-262 and Spo:52-368 
(Lanes 2 in Fig 2A, B and C) demonstrated that these peptides were at least 90 % 
pure. Occasionally, trace amounts ofGST at-27 k:Da were also detected in peptide 
samples. However, most preparations provided samples with about 99 % purity. 
Molecular masses as estimated from electrophoretic mobilities were -11 k:Da for the 
three peptides containing 105/106 amino acids (Spo:52-156, Spo:157-262 and 
Spo:263-368), -29 k:Da for peptides with two domains (Spo:52-262 and Spo:157-
368), and -37 k:Da for Spo:52-368. N-terminal sequencing of all six peptides 
confirmed the identities of the first 2 residues of each construct as GS (left from the 
thrombin cleavage site), followed by the appropriate residues of spectrin. TOF-
MALDI-mass spectral analysis of Spo:52-156, Spo:52-262 and Spo:52-368 
demonstrated that the peptide masses were 12.64, 24.86, and 37.05 k:Da, 
respectively, and were within 0.4 % of the theoretical masses (12.65, 24.87, and 
36.92 k:Da, respectively). 
Solution molecular masses obtained from 15 and 90 degree light scattering 
data for Spo:52-156, Spo:52-262 and Spo:52-368 in PBS were 10.4, 20.4, and 31.1 
kDa, respectively (Fig 1 ). These results clearly showed that these peptides, at 
concentrations of 0.1 - 1 mg/ml in PBS, existed in monomeric form. That these light 
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scattering measurements were able to detect oligomers of similar peptides was 
shown by measurements of the solution molecular mass of a protein encoding the 
first 446 amino acids of the spectrin sequence (Spal-446). This peptide exhibited 
substantial amounts of dimer and higher order oligomers, indicated by the arrows 
in Fig 1. 
Proteolysis of the peptides with elastase showed that they were all resistant 
to digestion, but to different extents. Intensities ofthe bands for Spa52-156 (11.3 
kDa, Fig 2A), Spa52-262 (28.8 kDa, Fig 2B) and for Spa52-368 (37.2 kDa, Fig 
2C) decreased as a function of elastase digestion time. The first order time 
constants (tg) for the disappearance of these bands were 1.1 h for Spa52-156, 2.3 
h for Spa52-262 and 3.5 h for Spa52-368. These data showed that Spa52-368 
resisted digestion the most, followed by Spa52-262, and finally by Spa52-156. The 
other two single-domain peptides (Spal57-262 and Spa263-368) exhibited 
digestion patterns (not shown) similar to those of Spa52-156. 
With prolonged incubation, multiple-domain peptides (Spa52-262, Spal57-
368 and Spa52-368) yielded digestion products of about 100 - 130 amino acid 
residues (12 - 15 kDa), corresponding to fragments presumably containing a single 
sequence motif of 106 amino acids. The enzyme cleavage sites for the N-terminal 
portion (residues 1-167) of spectrin were given earlier (15). The specific molecular 
masses measured for these products in Spa52-262 samples were 14.5 kDa 
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(appeared after 0.5 h incubation, Fig 2B) and 12.9 kDa (Fig 2B, lanes 7-11). 
Spa52-368 (37.2 kDa; Fig 2C, lane 2) was first digested to 30.2 and 27.8 kDa 
fragments (Fig 2C, lanes 4-11 ), corresponding to fragments containing two 
sequence motifs, and then to 14.2 kDa (Fig 2C, lanes 6-11), fragments containing 
a single sequence motif In each case, bands near but slightly larger than the 
expected size (14.5 and 12.9 kDa bands during the digestion of Spa52-262, when 
a single motif of about 11 kDa band was expected; and 30.2 kDa band for Spa52-
368 with two motifs of about 29 kDa band expected) probably reflects site 
preference specificity of elastase. In a previous study, we identified a similar 
product as being a whole domain plus the third helix of the previous domain (15). 
However, these larger fragments were not as stable as the smaller fragments, and 
were converted to the latter products over time. The fact that these products 
accumulated, while no products smaller than the expected size accumulated, 
emphasizes the intrinsic stability of these fragments. 
The implication of these results was that each 105/106 amino-acid-residue 
fragment, either as individual peptides (Spa52-156, Spa157-262 or Spa263-368) 
or· as components in larger peptides (Spa52-262, Spa157-368 or Spa52-368), 
formed compact structures that were resistant to internal proteolysis and thus had 
some domain-like properties. However, the individual domain structures in multi-
domain peptides (Spa52-262, Spa157-368 or Spa52-368) appeared to interact to 
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provide a structure more resistant to proteolytic digestion than in Spa52-156, 
Spa157-262 or Spa263-368. 
CD spectra of all peptides exhibited characteristics of high a-helical content. 
A typical spectrum of Spa52-262 in PBS at 20 °C (Fig 3A, solid line) consisted of 
a highly a-helical signature with double minima at 208 and 222 nm. Other peptides 
exhibited similar spectra, except with different <1>222 values (-18.7, -20.5, -18.4, -25.7 
and -27.4 x 103 deg cm dmof for Spa52-156, Spa157-262, Spa263-368, 
Spa157-368 and Spa52-368, respectively). These values corresponded to helical 
contents of 51 - 57 % for peptides with single domain, 71 - 83 % for peptides with 
two domains and 76 % for the peptide with three domains (Table 1 ). When treated 
similarly, the <1>222 value obtained for intact spectrin dimer corresponded to a 64 % 
helical content. This is consistent with a value of 69 % as measured by VCD (14), 
or 68 % as measured by CD (30). 
The FTIR central frequency of the main component of the amide I band 
(assigned to the a-helix of spectrin, see Ref. 14) was about1652 or 1653 cm·1 for 
peptides with single domain, 1650 or 1651 cm·1 for peptides with two or three 
domains (Table 1). The value for spectrin was 1650 cm·1 (14). Although these 
values were all indicative of a-helix structure, the frequency shifts reflected changes 
in hydrogen bond strength within helices, with lower frequencies corresponding to 
stronger or more extensive H-bonding networks (14). 
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In summary, both FTIR and CD data revealed that the spectrin peptides 
exhibited high helical contents, suggesting that these recombinant peptides were well 
folded, presumably as triple helical bundle for each 105/106 amino acid residues. 
These results are in good agreement with the elastase digestion results. However, 
the FTIR and CD measurements also indicated that peptides with single domain 
were slightly less well folded than peptides with multiple domains or intact spectrin. 
CD spectra of of our peptides at 75 °C were virtually featureless, implying 
that the peptides were extensively denatured from their native a-helical 
conformations at this temperature. The spectrum of Spa52-262 is shown as an 
example in Fig 3A, dotted line. Thermal denaturation as monitored by CD showed 
that Tm for single-domain peptides were 40, 48 and 50°C and for two-domain 
peptides were 50 and 56 °C. The Tm value was 54 °C for the three-domain peptide 
(Table 1 ). Thus thermal denaturation results suggested that peptides with single-
domain were less stable than peptides with multiple domains. Spectrin denatured 
at Tm = 4 7 ° C, indicating that at least portions of this molecule were in fact more 
sensitive to thermal stress. 
CD spectra of all peptides in the presence of 6 M urea at 20 ° C were also 
virtually featureless, again implying that the peptides were extensively denatured 
from its native a-helical conformations by urea treatments. The spectrum of a 
Spa52-262 sample is shown as example in Fig 3A, dashed line. Analysis of CD 
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spectra of all recombinant peptides and of spectrin as a function of urea 
concentration revealed that the urea denaturation profiles were well fitted by the 
two-state, single-transition model to give the parameter [Urea]mid· The mean values 
for [Urea]mid (Fig 3B, Table 1) for single domain peptides were 2.3 M for 
Spa52-156, 2.2 M for both Spal57-262 and Spa262-368, but 3.1 - 3.3 M for two-
domain peptides and 3.9 M for Spa52-368. The mean value for spectrin samples 
was 4.0 M (Fig 3B, Table 1). Again, these values indicated that single domain 
peptides (Spa52-156, Spal57-262 and Spa263-368) were the easiest to be 
unfolded by urea, followed by two-domain peptides (Spa52-262 and Spal57-368). 
The three-domain peptide (Spa52-368) was the most stable peptide with respect to 
urea unfolding. It was also interesting to note that the unfolding of the larger 
peptides was more cooperative than the unfolding of the smaller peptides (Fig 3B), 
suggesting interactions between domains in the larger peptides. 
Fluorescence urea denaturation data of all peptides except Spa52-262 (for 
example see data for Spa52-156, Spa52-368 and spectrin in Fig 4) were all well 
fitted by the two-state, single-transition model used for the CD denaturation 
experiments. The mean values for [Urea]mid ranged from 0.04 - 2.5 M for single-
domain peptides, 2.8 - 3.2 M for two-domain peptides, but were 3.6 M for Spa52-
368 and 4.1 M for spectrin samples (Table 1). The wavelength with maximum 
intensity (A.maJ of Spa52-368, for example, moved from 345 nm to 351 nm (red 
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shifted) in the presence of 6 M urea, indicating that the fluorophores ( tryptophan 
residues) moved from a relatively hydrophobic, solvent-inaccessible environment to 
a more polar, solvent-exposed environment. This is consistent with published work 
showing that tryptophan residues in similar spectrin fragments are in a shielded 
hydrophobic environment and appear to form a folding nucleation site (31 ). The 
general close correlation of the values of [Urea]mid measured by both CD and 
fluorescence techniques indicated that the two processes (unfolding of helical 
structures monitored by CD, and the release of buried tryptophan residues to more 
exposed solvent environment monitored by fluorescence) were generally linked. 
Spa52-262 exhibited a unique, second transition at a lower urea 
concentration in fluorescence studies (Fig 4). The data were analyzed with three-
state model to include an intermediate state. The mean value for [Urea]mid for the 
first transition was about 0.4 M. The second transition was at about 3.2 M (Fig 4), 
a value similar to those of peptides that exhibited only a single transition. The low 
urea transition was most evident in the blue end of the emission spectra. The change 
was primarily one of quenching, with only a small red shift evident (A.max moved from 
347 to 353 nm). The high urea concentration transition resulted in a larger red shift 
(A.max moved from 353 to 362 nm) with a slight intensity increase. These results 
show the merit of using A.mean (Fig 4) as the parameter reflecting unfolding. If a 
single wavelength were used, in addition to producing noisier data, only one of the 
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transitions might be detected without significant contribution of the other. For 
example, a transition at urea concentration of about 0.4 M was easily seen when the 
fluorescence intensity at 3 20 run was examined, but there was little indication that 
another transition occurred at higher urea concentrations. Conversely, when the 
intensity at 370 run was examined, a transition near 3.2 M was observed, with no 
sign of the transition at urea concentration less than 1 M. 
The possibility that the low urea transition was an artifact of incomplete 
equilibration was eliminated by examining the rate at which these peptides reached 
equilibrium in the presence of 4 M urea. It was found that the Spcx52-156 samples 
reached their final denatured states very rapidly (within 1 min at 20 °C). In other 
samples (Spcx52-262, Spcx52-368 and spectrin), the data were fitted best with a bi-
exponential decay, with a fast phase and a slow phase. The fast phase with 't'n < 
0.02 h (~ 1 min) was poorly defined due to the paucity of data at this time scale and 
will not be further considered. The time constant for the slow phase (-rf2) was 0.6 h 
for Spa52-262 and 1.3 h for Spa52-368, and 1.9 h for spectrin. Clearly our 
incubation time of 16 - 17 h was sufficient for our samples to reach thermodynamic 
equilibrium in the denaturation studies. The additional possibility that these 
secondary transitions reflect oligomerization equilibria was considered, since some 
of these spectrin recombinant peptides appear to undergo self association (9, 32). 
However, the observed solution masses for our peptides clearly showed that they 
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existed as monomers in solution under the experimental conditions used for CD and 
fluorescence measurements. 
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(g) DISCUSSION 
Common assumptions made in the study of proteins containing repetitive 
sequence motifs, such as spectrin, are that each repetitive sequence motif folds into 
a structural domain, and that these domains are similar to each other and constitute 
classical independent structural units. Thus, when structures of parent proteins are 
difficult to obtain, peptides of a single sequence motif of the parent protein are often 
used to study the structure of the parent protein. However, that a polypeptide can 
form a stable structure is a necessary, but not sufficient, cause for it to be considered 
as an individually folded, independent structural unit. Independence of folding and 
stability need to be demonstrated experimentally. Such demonstrations entail 
examining the properties of the individual domains in isolation, which must be 
substantially similar to those of the structures when present in the parent protein. 
In the case of proteins containing spectrin-like sequence motifs, the hypothesis that 
each sequence motif folds into an independent structural unit has been supported by 
two main lines of evidence: resistance to proteolysis, which pertains to the first 
folding criteria, and spectroscopic (CD and fluorescence) evidence which pertains 
to the latter phenomenological criteria. 
Proteolytic resistance has been widely used and has been employed to study 
fragments containing different repetitive sequences of various spectrins (15, 16), of 
actinin (17) and ofdystrophin (18). The basis of this approach is that a polypeptide 
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that is a complete domain will be able to fold into a compact structure. Since 
proteolytic sensitivity is correlated to the flexibility (33) and accessibility (34) of 
peptide structures, these putative domains will be resistant to proteolysis while 
intervening regions will be susceptible. In all of the above studies, polypeptides 
expressed became resistant to proteolysis only when they spanned a complete 
sequence motif and when they started at a specific point within the sequence motif 
(i.e., they were expressed in the proper phase). Our earlier work showed that a 
properly phased spectrin sequence motif, containing residues 52-156, was resistant 
to proteolysis whereas a fragment containing an alternative phasing, containing 
residues 49-155, for example, was much less (> 10 fold) resistant to proteolysis 
(15). An additional incomplete repetitive sequence motif on either end of a 
complete sequence motif was rapidly digested, showing that while each complete 
sequence motif could form a compact structure, fractional sequence motifs could 
not. Gratzer and co-workers expressed fragments of dystrophin (18) and 
demonstrated that properly phased single sequence motifs exhibited a high 
proportion of a-helix as measured by CD, while improperly phased sequence motifs, 
differing by only a few amino acids, exhibited much lower helicity. These 
experiments clearly showed that these single spectrin-like sequence motifs could fold 
into a compact structure, which might be true domains. However, one hint that 
these structures exhibit some cooperativity comes from the observation that when 
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two sequence motifs of actinin are expressed in tandem, they are more resistant to 
proteolysis than either of the isolated constituent motifs, a terminal fractional motif, 
or improperly phased motifs (17). 
We found that fragments containing one (first, second, or third), two (first 
two or second and third), and three (first three) sequence motifs of a-spectrin were 
all relatively stable to proteolysis, but eventually succumbed to digestion and 
produced fragments of about 11-12 kDa, the size of a single sequence motif These 
results suggest that, although the single sequence motifs in these multi-motif 
peptides form some sort of self-contained and protease-resistant structure, their 
structures are not completely independent, with Spa52-156, Spa157-262 and 
Spa263-368 being the least resistant to elastase, followed by Spa52-262 and 
Spa157-368, and finally by Spa52-368. 
Our structural integrity studies indicate a similar stability series. All data, 
including the FTIR, CD, and/or fluorescence spectra, indicated that the peptides 
with a single domain (Spa52-156, Spa157-262 and Spa263-368) were folded into 
compact structures that contained substantial a-helix (about 55 %). However, the 
peptides with multi-domains (Spa52-262, Spa157-368 and Spa52-368) exhibited 
higher helical contents (about 75 % or more). FTIR results indicated that single-
domain peptides exhibited frequency value at 1652-1653 cm·1, slightly shifted from 
the values seen for the other peptides (1650 - 1651 cm-1). Since the exact position 
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of this band within the amide I region has been correlated to hydrogen bond 
strength, this indicates that the hydrogen bonds in single-domain peptides are slightly 
weaker than that in the other multiple-domain peptides, consistent with a slightly 
expanded structure. 
The amount of denaturant needed to disrupt these structures also increased 
along the same stability series, with Spa52-368 being the most stable and 
Spa52-156, Spa157-262 and Spa263-368 being the least stable ones. This 
stabilization was also seen kinetically with rates of denaturation being much slower 
for the larger peptides, as well as with thermal denaturation, in which the Tm values 
measured were greater for the larger peptides. In all measurements involving 
denaturation, Spa52-368 was most similar to intact spectrin and the single-domain 
peptides least similar. 
Thus, our data suggest that the spectrin repetitive sequence motifs are not 
classical independent structural domains, but rather are interactive stabilizing sub-
structures. This may have some bearing on the functional properties of spectrin and 
in particular to its role in some genetic diseases, such as hereditary elliptocytosis 
(HE) and hereditary pyropoikilocytosis (35). These diseases are often associated 
with spectrin mutations, which result in reduced levels of spectrin in the membrane 
skeleton (36, 37). Erythrocyte membrane integrity relies on a number of interactions 
of spectrin with itself and with other membrane proteins, as well as with lipids, but 
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interactions especially germane to this study are the head-to-head interactions 
between the ap spectrin dimers to form the ( ap)2 spectrin tetramers. Since the 
dimer-dimer interaction is primarily thought to be the result of the complementary 
association of sequences in the first 50 residues of a-spectrin with a region at the C-
terminus of P-spectrin to form a stable hetero-polypeptide triple a-helical bundle 
(38), it is easy to see how mutations at the terminal ends involved in this interaction 
may disrupt this process and lead to decreased interaction. Many such mutations are 
known and indeed these altered spectrin molecules show impaired self-association 
(39). It is less easy to see how mutations distal to regions involved in direct 
interaction, and as far as four sequence motifs (> 400 amino acids) away could 
disrupt dimer-dimer self association; however such mutations are known. For 
instance, a spectrin variant, Alexandria, with a deletion of a histidine at position 469 
in the a-spectrin chain, exhibits decreased tetramerization (as measured by 
perturbation of the dimer-tetramer equilibrium in 4 ° C extracts of erythrocyte 
membranes) (40). Similarly, a HE spectrin variant, Sfax, resulting in the splicing out 
of codons 363 to 371 in helix three of the fourth sequence motif(41) also shows 
increased levels of spectrin dimers and by inference reduced dimer-dimer 
association. The conclusion to be drawn from these unusual spectrin mutations in 
HE patients is that mutations distal to the dimer self-association site may have their 
effects propagated through the intervening domains to the association site by 
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mechanisms that would imply communication and thus cooperativity between the 
structural units that are formed by these domains. Thus, clinical observations 
corroborate our experimental evidence based on proteolytic and denaturant stability, 
implying that the spectrin-like-sequence motif, while forming structures with limited 
independence of function, are not truly independent domains. Our data also 
demonstrate that the structural properties of peptides of single sequence motifs 
differ from those of spectrin molecules. There appears to be substantial 
communication between structural domains containing these sequence motifs, and 
in order to adequately mimic the properties of spectrin several tandem domains must 
be considered. 
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(i) FOOTNOTES 
i Spai-j - Human erythroid a-spectrin recombinant peptide composed of residues i 
to j; A280 - absorbance at 280 nm; CD - circular dichroism; ~G- free energy change 
in unfolding; FTIR - Fourier transform infrared; ~222 - CD ellipticity at 222 nm; HE -
hereditary elliptocytosis; IA - fluorescence intensity at wavelength A; Amean - mean 
emission wavelength; Amax - wavelength with maximum intersity; PBS - 5 mM 
phosphate buffer containing 150 mMNaCl at pH 7.4; 'tn - time constant for the fast 
phase in urea unfolding (from fluorescence results); 1:12 - time constant for the slow 
phase in urea unfolding (from fluorescence results); 1:8 - time constant for the 
disappearance of peptide by elastase digestion (from gel data); U - urea 
concentration; [Urea ]mid - mean urea concentrations for transition from native to 
denatured state; Tm - temperature of maximum value of 3~222/c>T. 
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fj) FIGURE LEGENDS 
Figure 1 
Figure 2 
Solution molecular mass distribution of Spa52-156 (solid line), 
Spa52-262 (dashed line) and Spa52-368 (dotted line) in PBS, 
obtained from light scattering results. These peptides exhibit single 
peaks at 10.4, 20.4 and 31.1 kDa, respectively. The concentrations 
of the samples in PBS ranged from 0.1 to 1 mg/ml. The molecular 
masses are all near the theoretical masses for monomers. The ability 
of this technique to discern oligomerization is demonstrated by the 
presence of substantial dimer (large arrow) and trimer (small arrow) 
populations in another peptide, S pcx 1-446 (dash-dotted line). 
SDS-PAGE of elastase digestion products of Spcx52-156 (Panel A), 
Spa52-262 (Panel B) and Spa52-368 (Panel C). The first lane in 
each gel contained molecular weight standards (43.0, 29.0, 18.4, 
14.3 and 6.2 kDa). Subsequent lanes (lanes 2 - 11) contained an 
aliquot of each digestion reaction quenched at various times: 0, 0. 5, 
1, 1.5, 2, 3, 4, 5, 6 and 7 h. Intensities of the band for Spa52-156 
(11.3 kDa, Panel A), for Spa52-262 (28.8 kDa, Panel B) and for 
Spa52-368 (37.2 kDa, Panel C) decreased as a function of elastase 
digestion time. Spa52-262 eventually yielded fragments at 14.5 and 
12.9 kDa, and Spa52-368 yielded fragments at 14.2 kDa. The sizes 
Figure 3 
Figure 4 
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of these fragments were similar to the size of Spa52-156. Spa52-
368 also yielded intermediate fragments at 30.2 and 27.8 kDa, 
similar in size to Spa52-262. The band at 27 kDa (Panel B, under 
the Spa52-262 band) exhibited constant intensity throughout the 
incubation, and was assumed to be that of contaminating GST. 
CD Spectra and CD Monitored Denaturation. A. Typical CD 
Spectrum of Spa52-262. The CD spectrum of Spa52-262 was 
recorded in PBS at 20°C (solid line), PBS at 75 °C (dotted line), 
and PBS plus 6 M urea (dashed line). The highly a-helical signature 
in Spa52-262 spectrum in PBS gave way to a virtually featureless 
spectrum when the peptide was denatured by either temperature or 
urea. Other peptides exhibited substantially similar spectra, except 
with different maximal signal intensities. See text for detailed 
discussions. B. Urea mediated denaturation was monitored by CD 
(<1>222 ) for Spa52-156 (square •), Spa52-262 (triangle .6.), 
Spa52-368 (diamond+), and spectrin (circle 0). All peptides show 
a single transition. 
Fluorescence Monitored Denaturation. Fluorescence studies of urea 
denaturation of Spa52-l 56, Spa52-262, Spa52-368 and spectrin 
samples. Urea mediated denaturation was monitored by 
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fluorescence for Spa.52-156 (square•), Spa.52-262 (triangle•), 
Spa.52-368 (diamond +), and spectrin (circle 0). The mean 
emission wavelength )..mean at each urea concentration was used. All 
proteins show a red shift upon denaturation. Spa.52-156 started 
from a longer wavelength ( Amean - 3 50 nm) than the others, (Amean -
344 nm). This may indicate a lesser degree of compaction in this 
peptide. Spa.52-262 shows two transitions, one at high urea 
concentration to a denatured state, and one at low urea 
concentration between a seemingly completely folded state, with a 
A.mean - 345 nm, and an incompletely folded intermediate with a A.mean 
- 349 nm, similar to that of native Spa.52-156. 
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(k) TABLES 
Table 1 Structural Properties Derived from Various Spectroscopic and 
Proteolytic Results of Spectrin Peptides and of Spectrin Molecules 
in PBS 
CD 
Fluorescence 
Protein Amide I (cm·1t a-helix (%)c Irn-CCt [Urea]mi~ UJmUnm!M) 
Spo:52-156 1652.7 52 40 2.3 2.5 
Spa157-262 1651.5 57 50 2.2 0.04 
Spo:263-368 1651.9 51 48 2.2 2.0 
Spo:52-262 1650.2 83 50 3.3 3.2 
Spo:157-368 1650.9 71 56 3.1 2.8 
Spo:52-368 1651.3 76 54 3.9 3.6 
Spectrin 1649.9 64 47 4.0 4.1 
3Generally, the values presented in this Table were mean values of 3-4 experimental 
runs. Maximum standard deviations were given below. b Amide I frequency values 
from FTIR measurements provide information on hydrogen bond strength in helices. 
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Standard deviations were less than 0.3 cm·1. ca-helical contents(%) were calculated 
from cl>222 values of CD spectra at 20 °C, using the value 36,000 degree cm2 dmo1·1 
for 100 % helix. The calculations of this and other parameters in this table were 
discussed in detail in the Experimental Procedures section. Standard deviations were 
less than 5 %. ctr m was the temperature of maximum value of l>ct> 221/ 5 T. Standard 
deviations were less than 1 °C. e[Urea]mid was mean urea concentrations for the 
transition to the denatured state obtained from CD or fluorescence results. Standard 
deviations were less than 0.2 M. 
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